<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01//EN" "http://www.w3.org/TR/html4/strict.dtd">
<!--
-->
<!-- %html{'xmlns'=>'http://www.w3.org/1999/xhtml', 'xml:lang'=>'en', 'lang'=>'en'} -->
<html>
<head>
<script type="text/javascript">window.NREUM||(NREUM={});NREUM.info={"beacon":"beacon-1.newrelic.com","errorBeacon":"jserror.newrelic.com","licenseKey":"d64d3db899","applicationID":"125361","transactionName":"dAkNQBFbXFUEREkBCVQTDlENQB9dDlUTCANZEkxHC1tH","queueTime":0,"applicationTime":3344,"ttGuid":"","agentToken":null,"agent":"js-agent.newrelic.com/nr-298.min.js","extra":""}</script>
<script type="text/javascript">window.NREUM||(NREUM={}),__nr_require=function a(b,c,d){function e(f){if(!c[f]){var g=c[f]={exports:{}};b[f][0].call(g.exports,function(a){var c=b[f][1][a];return e(c?c:a)},g,g.exports,a,b,c,d)}return c[f].exports}for(var f=0;f<d.length;f++)e(d[f]);return e}({"4O2Y62":[function(a,b){function c(a,b){var c=d[a];return c?c.apply(this,b):(e[a]||(e[a]=[]),void e[a].push(b))}var d={},e={};b.exports=c,c.queues=e,c.handlers=d},{}],handle:[function(a,b){b.exports=a("4O2Y62")},{}],YLUGVp:[function(a,b){function c(){var a=m.info=NREUM.info,b=m.proto="https"===l.split(":")[0]||a.sslForHttp?"https://":"http://";if(a&&a.agent&&a.licenseKey&&a.applicationID){f("mark",["onload",e()]);var c=h.createElement("script");c.src=b+a.agent,h.body.appendChild(c)}}function d(){"complete"===h.readyState&&f("mark",["domContent",e()])}function e(){return(new Date).getTime()}var f=a("handle"),g=window,h=g.document,i="readystatechange",j="addEventListener",k="attachEvent",l=(""+location).split("?")[0],m=b.exports={offset:e(),origin:l};h[j]?(h[j](i,d,!1),g[j]("load",c,!1)):(h[k]("on"+i,d),g[k]("onload",c)),f("mark",["firstbyte",e()])},{handle:"4O2Y62"}],loader:[function(a,b){b.exports=a("YLUGVp")},{}]},{},["YLUGVp"]);</script>
<title>
Schedin v. Ortho-McNeil-Janssen Pharm., Inc., 700 F.3d 1161 (8th Cir. 2012), Court Opinion - Bloomberg Law 

</title>
<meta content='NOINDEX, NOFOLLOW' name='ROBOTS'>
<meta content='telephone=no' name='format-detection'>
<meta content='BLAW' name='apple-mobile-web-app-title'>
<meta name="csrf-param" content="authenticity_token"/>
<meta name="csrf-token" content="NiJ+70&#47;qv61N1TFnbttr4ZzRa7IGhB5DMvou0CKGUXA="/>
<script src="/min_assets/framework.js?1389213936" type="text/javascript"></script>

<script src="/javascripts/daterange.js?1380743058" type="text/javascript"></script>
<script src="/javascripts/document/document.js?1382459272" type="text/javascript"></script>
<script src="/javascripts/document/document_viewer.js?1383685414" type="text/javascript"></script>
<script src="/javascripts/document/bciteutils.js?1388683076" type="text/javascript"></script>
<script src="/javascripts/jquery/jquery.query.js?1342203941" type="text/javascript"></script>
<script src="/javascripts/browser/browser.js?1387565892" type="text/javascript"></script>
<script src="/javascripts/document/image_viewer.js?1366129555" type="text/javascript"></script>
<script src="/javascripts/jquery/jquery.selection.js?1375450295" type="text/javascript"></script>
<script src="/javascripts/jquery/jquery.bb-copywithcitation.js?1383771008" type="text/javascript"></script>
<script src="/javascripts/document/copy_with_cite.js?1382560939" type="text/javascript"></script>
<script src="/javascripts/document/notepad.js?1366310522" type="text/javascript"></script>

<link href="/stylesheets/yui2/yui2_combo.css?1288273584" media="print,screen" rel="stylesheet" type="text/css" />
<link href="/stylesheets/document_v2.css?1391022004" media="print,screen" rel="stylesheet" type="text/css" />
<link href="/min_assets/framework.css?1391022047" media="screen,print" rel="stylesheet" type="text/css" />
<!--[if IE]>
<link href="/stylesheets/ie.css?1391022010" media="screen,print" rel="stylesheet" type="text/css" />
<![endif]-->
<link href="/stylesheets/search/search_results.css?1391022036" media="print,screen" rel="stylesheet" type="text/css" />
<link href="/stylesheets/document.css?1391022003" media="print,screen" rel="stylesheet" type="text/css" />
<link href="/stylesheets/document_viewer.css?1391022005" media="print,screen" rel="stylesheet" type="text/css" />
<link href="/stylesheets/search/tree_view.css?1391022037" media="print,screen" rel="stylesheet" type="text/css" />
<link href="/stylesheets/browser/browser_enhanced.css?1391021984" media="print,screen" rel="stylesheet" type="text/css" />
<style type='text/css'>
#content_document, #content_document h1, #content_document h2, #content_document h3, #content_document h4, #content_document h5, #content_document h6 { font-family:Times New Roman, Times, serif; }
				#content_document pre {
				white-space: pre-wrap;
				white-space: -moz-pre-wrap;
				white-space: -pre-wrap;
				white-space: -o-pre-wrap;
				word-wrap: break-word;
				font-family: Bloomberg Fixed 2 Unicode;
			}
			
			#content_document .page_no { 
				font-weight:bold;
				text-decoration:none;
			}
			
			#content_document .highlight { 
				font-weight:bold; 
				background-color:yellow; 
				color:black;
			}
			
			#content_document .bcitehi { 
				font-weight:bold; 
				background-color:violet; 
				color:black;
			}
			
			/*.UNICODE {
			}
			
			#content_document blockquote {
			}
			
			#content_document em {
			}   
			
			#content_document .tableofcontents {
			}
			
			#content_document div.blockgroup {
			}
			
			#content_document p.opinion_text {
			}  */
			
			#content_document, #content_document h1, #content_document h2, #content_document h3, #content_document h4, #content_document h5, #content_document h6, #content_document p, #content_document li, #content_document td, #content_document th, #content_document div {
				font-size: 11pt;
			}
			
			#content_document .main {
				text-align:center; 
				font-weight:bold; 
				color:black;
			}
			
			#content_document .ftnote { 
				font-style:italic;
			}
			
			#content_document .headline {
				font-weight:bold; 
				color:black;
			} 
			
			#content_document p.group{
				padding-top: 0; 
				padding-bottom: 1px; 
				padding-left: 0; 
				padding-right: 0;
				margin-top: 0; 
				margin-bottom: 1px; 
				margin-left: 0; 
				margin-right: 0;
			}
			
			#content_document .big {
				font-size: 13pt;
			}
			
			#content_document .indent {
				text-indent:2.5em;
			}
			
			#content_document .level2 {
				margin-left:2.5em;
				margin-right:2.5em;
			} 
			
			#content_document .level3 {
				margin-left:5em;
				margin-right:5em;
			} 					
			
			#content_document .level4 {
				margin-left:7.5em;
				margin-right:7.5em;
			} 					
			
			#content_document .level5 {
				margin-left:10em;
				margin-right:10em;
			} 					
			
			#content_document .level6 {
				margin-left:12.5em;
			} 					
			
			#content_document a.sup {
				font-size: 6pt; 
				vertical-align: top;
			}
			
			#content_document a.sup1 {
				font-size: 8pt; 
				vertical-align: top;
			}
			
			#content_document em.italic {
				font-style: italic;
			}
			
			#content_document em.bold {
				font-weight: bold;
				font-style: normal;
			}
			
			#content_document em.bold-big {
				font-size: 13pt; 
				font-weight: bold;
			}
			
			#content_document em.underline {
				font-style:normal; 
				text-decoration: underline;
			}
			
			#content_document em.bold-ital {
				font-weight: bold; 
				font-style: italic;
			}
			
			#content_document em.bold-underline {
				font-weight: bold; 
				text-decoration: underline;
			}
			
			#content_document em.ital-underline {
				font-style: italic; 
				text-decoration: underline;
			}
			
			#content_document em.ital-bold-underline { 
				font-style: italic; 
				font-weight: bold; 
				text-decoration: underline;
			}
			
			#content_document em.small-cap {
				font-style:normal; 
				font-variant: small-caps;
			}
			
			#content_document em.strike {
				font-style: normal;
				text-decoration: line-through;
			}
			
			#content_document .small-cap {
				font-style:normal; 
				font-variant: small-caps;
			}
			
			#content_document h1.organization {
				font-weight: bold; 
				text-align:center; 
				font-style: normal;
			} 
			
			#content_document h2.organization {
				font-weight: bold; 
				text-align:left;
				margin-left:2.5em; 
				margin-right:2.5em;
			}
			
			#content_document h3.organization {
				font-weight: bold; 
				text-align:left;
				margin-left:5em; 
				margin-right:5em;
			}
			
			#content_document h4.organization {
				font-weight: bold;
				text-align:left;
				margin-left:7.5em; 
				margin-right:5em;
			}
			
			#content_document h5.organization {
				font-weight: bold; 
				text-align:left;
				margin-left:10em; 
				margin-right:5em;
			}
			
			#content_document h2.citation {
				font-weight: bold; 
				text-align:left;
			}
			
			#content_document div.blcitation {
				font-size: 7pt; 
				text-align:center;
			}
			
			#content_document .italic {
				font-style:italic;
			}	
			
			#content_document ul.dash {
				list-style-type: none;
			}
			
			#content_document ul.bullet {
				list-style-type: disc;
			}
			
			#content_document ul.none {
				list-style-type: none;
			}
			
			#content_document li.off {
				list-style-type: none; 
			}
			
			#content_document .mypre { 
				font-size: 100%;
			}
			
			#content_document .TOC {
				text-align:left;  
				padding:5px;  
				margin:0 auto;  
				color: #000000;  
				font-weight: 500;
			}
			
			#content_document .TOC hr { 
				color:#339999;  
				background-color:#339999;  
				width:100%;  
				clear: both;  
				border: none;
			}
			
			#content_document .bluehr { 
				color:#339999;  
				background-color:#339999;  
				width:100%;  
				clear: both;  
				border: none;
			}
			
			#content_document .headinga { 
				color: #339999;   
				font-size: 20px;
				font-weight: 500;
				text-align: center;
			}
			
			#content_document .tocentry {
				text-indent:-18px;
				padding-left:18px;
				color: #003399;
				font-weight: 700;
			}
			
			#content_document .doctext {  
				margin:0 auto;  
				text-align: left;  
			}				 
			
			#content_document span.PAGE { 
				color: black; 
				font-weight: bold 
			}
			
			#content_document a:link {  	
				color: #003399;  
				font-weight: 700;
			}
			
			#content_document a:visited {  
				color: #660066;   
				font-weight: 700;
			}
			
			#content_document .fn{  
				padding-left: 50 px; 
				font-weight: 550;
			}				
			
			#content_document .fr a:link {  
				color: #003399;  
				font-weight: 600;
			}
			
			#content_document .fr a:visited {  
				color: #660066;  
				font-weight: 600;
			}
			
			#content_document .headinga { 
				color: #339999;   
				font-size: 20px;
				font-weight: 600;
				text-align: center;
			}
			
			#content_document .volume {  
				text-align:center;  
				padding:5px;  
				margin:0 auto;  
				color: #000000;  
				font-weight: 500;
			}				
			
			#content_document h2.blcitation {
				font-size: 7pt; 
				text-align:center; 
				white-space:nowrap;
			}
			
			#content_document cite.blcitation {
				white-space:nowrap;
			}
			
			#content_document table.page_legend { 
					width: 100px; 
					text-align: left; 
					background-color: white; 
					font-family: Bloomberg Proportional Unicode;
					font-size: 12px
			}
			#content_document div.page_text {  padding-left: 50 px; margin:0 0 0 50px;  text-align: center;  width:100px; font-size: 12px}

			#content_document .smalllinks{  text-align: right;  font-size: 10px;  font-weight: 500;}		
			
			#content_document .opinion_headnotes{
				margin-top:6px;
				margin-bottom:6px;
			}
			
			#content_document .headnote_group{
				padding: 10px 10px 2px 10px;
				background-color: #ECECEC;
				margin-top:4px;
				margin-bottom:10px;
			}
			
			#content_document .headnote_group_header{
				font-weight: bold;
				margin-bottom: 8px;
			}
			
			#content_document .opinion_headnote{
				clear:both;
				padding-bottom: 4px;
				margin-bottom:10px;
			}
			
			#content_document .highlighted_headnote{
				background-color: #FFFF22;
			}
			
			#content_document .headnote_link{
				font-weight:bold;
				text-decoration: none;
			}
			
			#content_document .show_hide_headnotes{
			}
			
			#content_document .clearfix:after {
				clear:both;
				content: ".";
				height:0px;
				display:block;
				visibility:hidden;
			}
			
			/* BNA Headnotes */
			
			#content_document .headnotesContainer {
				margin: 12px 0;
				padding: 12px 0;
				border-top: 1px solid #000;
				border-bottom: 1px solid #000;
			}
			
			#content_document .headnotesContainer .headnotesContainerTitle {
				font-size: 16px;
				font-weight: bold;
				text-align: center;
			}
			
			#content_document .headnotesContainer .headnoteTitle {
				padding: 8px 12px;
				background-color: #dedede;
				margin: 24px 0 0 0;
				font-size: 16px;
				font-weight: bold;
				text-transform: uppercase;
			}
			
			#content_document .headnotesContainer .headnote {
				margin-left: 24px;
			}
			
			#content_document .headnotesContainer .headnote .headnoteSlug {
				margin-top: 12px;
				font-size: 16px;
				font-weight: bold;
			}
			
			#content_document .headnotesContainer .headnote .headnoteDescriptor {
				margin-top: 12px;
				font-weight: bold;
			}
			
			#content_document .headnotesContainer .headnote .headnoteToggle .headnoteText {
				margin-bottom: 12px;
			}
		
</style>
<link href="/stylesheets/yui_calendar.css?1391022047" media="print,screen" rel="stylesheet" type="text/css" />
<link href="/stylesheets/docviewer_overrides.css?1391022005" media="print,screen" rel="stylesheet" type="text/css" />

<link href="/stylesheets/print.css?1391022029" media="print" rel="stylesheet" type="text/css" />
<link href='/images/favicon.ico' rel='shortcut icon'>
</head>
<body class='securities  document '>
<div class='container'>
<div id='page_loader'></div>
<div class='printHeader printOnly'>
<img src='/images/print_header.jpg'>
<div class='user'>
<span>
Prepared for: Susan Yeh
</span>
</div>
</div>
<div class='topBarHolder printHide'>
<div class='topBar'>
<ul class='topBarElements'>
<li class='skip'>
<a href="#primary_content" tabindex="1">Skip Navigation</a>
</li>
<li class='logout'>
<a href="/log_out.htm" id="logoutButton" onclick="generateExplicitLogoutEvent();">Logout</a>
</li>
<li id='help'>
<a href="/help" target="_blank">Help</a>

</li>
<li id='user'>
<a href="/settings">Susan Yeh</a>

</li>
<li class='withNotifications' id='client_matter'>
<div class='clientMatterDropDown'>
<div>Client Matter</div>
<div class='skinButton blueAlert' style='display:none'>
<span id='currentClientMatter'>

</span>
</div>
<span class='noneSelected' style=''>
&nbsp;(None Selected)
</span>
<div class='expandable'></div>
</div>
<div class='topNavDropdown' id='sub_client_matter'>
<ul>
<li style='display:none'>
<a class='remove_client_matter_menu_item' href='#' onclick='return true;' title='Remove Current Client Matter'>
Remove Current Client Matter
</a>
</li>
<li>
<a class='enter_client_matter_menu_item' href='#' onclick='return true;' title='Enter Client Matter'>
Enter Client Matter
</a>
</li>
</ul>
</div>

</li>
<li class='withNotifications' id='alerts'>
<a href="/alerts/inbox"><div id='unreadAlertsCount'>
Saved Searches & Alerts
</div>
</a>
</li>
<li class='withNotifications' id='downloads'>
<a href="/download/download_center"><div id='unreadDownloadsCount'>
<div>Downloads</div>
</div>
</a>
</li>
<li id='research_trail'>
<a href="/research_trail"><div>Research Trail</div>
</a>
</li>
<li id='workspaces'>
<a href="/workspaces"><div>Workspaces</div>

</a></li>
</ul>
</div>
</div>

<div class='topMenu textBkDark printHide' id='top_menu'>
<div class='contextHolder'>
<a href='/home'>
<h1 class='logo'></h1>
</a>
<div class='menuRow'>
<ul class='menuItems'>
<li class='' id='nav_menu_button'>
<a class='nav_menu_button ' id='nav_menu_button_HOME' onclick="javascript:navigation_selectMenuItem('HOME');">
Home
</a>
</li>
<li class='' id='nav_menu_button'>
<a class='nav_menu_button active' id='nav_menu_button_search' onclick="javascript:navigation_selectMenuItem('search');">
Search & Browse
</a>
</li>
<li class='' id='nav_menu_button'>
<a class='nav_menu_button ' id='nav_menu_button_practice_areas' onclick="javascript:navigation_selectMenuItem('practice_areas');">
Practice Centers
</a>
</li>
<li class='' id='nav_menu_button'>
<a class='nav_menu_button ' id='nav_menu_button_LITIGATION' onclick="javascript:navigation_selectMenuItem('LITIGATION');">
Litigation & Dockets
</a>
</li>
<li class='' id='nav_menu_button'>
<a class='nav_menu_button ' id='nav_menu_button_transactional' onclick="javascript:navigation_selectMenuItem('transactional');">
Transactional Law
</a>
</li>
<li class='' id='nav_menu_button'>
<a class='nav_menu_button ' id='nav_menu_button_LEG_REG' onclick="javascript:navigation_selectMenuItem('LEG_REG');">
Legislative & Regulatory
</a>
</li>
<li class='legalAnalysis' id='nav_menu_button'>
<a class='nav_menu_button ' id='nav_menu_button_news' onclick="javascript:navigation_selectMenuItem('news');">
Legal Analysis & News
</a>
</li>
<li class='last' id='nav_menu_button'>
<a class='nav_menu_button ' id='nav_menu_button_market' onclick="javascript:navigation_selectMenuItem('market');">
Companies & Markets
</a>
</li>

</ul>
</div>
<form accept-charset="UTF-8" action="/autocomplete/jump" id="search_form" method="post"><div style="margin:0;padding:0;display:inline"><input name="utf8" type="hidden" value="&#x2713;" /><input name="authenticity_token" type="hidden" value="NiJ+70/qv61N1TFnbttr4ZzRa7IGhB5DMvou0CKGUXA=" /></div>
<input id='quicksearch_context' name='context_value' type='hidden' value='PRACTICE'>
<div class='searchBox' id='quick_search'>
<div class='inputContainer'>
<input autocomplete='off' id='quick_search_term' name='term' onkeydown='framework_handleTextInput(event,quick_search_term)' tabindex='2' type='text'>
<div class='searchButton' onmouseup='return framework_activateForm();' tabindex='3'></div>
<a href="/help/BLAWHelpSystem.htm#GO_Using_the_GO_BAR.htm" class="infoBtn" target="_blank" title="Using the &lt;GO&gt; Bar"></a>
<input id='quick_search_post' name='qs_type' type='hidden' value='general'>
<input id='quick_search_type' name='type' type='hidden' value='input_terms'>
<input id='quick_search_value' name='item_value' type='hidden'>
<input id='quick_search_origin' name='search_type' type='hidden' value='LAW'>
</div>
</div>
</form>


</div>
</div>

<div class='main clearfix'>
<div class='menuDrawer'>
<div class='interior'>
<div class='drawer_shade drawerShade clearfix'>
<div class='dropShadow'></div>
<div class='sub_menu subMenu' id='sub_menu_HOME'>
<table>
<tr>
<td class=''>
<ul>
</ul>
</td>
</tr>
</table>
</div>
<div class='sub_menu subMenu' id='sub_menu_search'>
<div class='subTitles'>
<div class='subItem one '>
Search
</div>
<div class='subItem two '>
Specialized Searches
</div>
<div class='subItem one last'>
Browse
</div>
<div class='clearfix'></div>
</div>
<table>
<tr>
<td class=''>
<ul>
<li class='last'>
<a class='clearfix' href='/legal_search'>
<div class='navLinkTitle'>
All Legal Content
</div>
</a>
</li>
</ul>
</td>
<td class='subNavGutter'></td>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/company_search'>
<div class='navLinkTitle'>
Company Screener
</div>
</a>
</li>
<li>
<a class='clearfix' href='/opinion_search'>
<div class='navLinkTitle'>
Court Opinions
</div>
</a>
</li>
<li>
<a class='clearfix' href='/dealmaker_document_search'>
<div class='navLinkTitle'>
DealMaker Documents
</div>
</a>
</li>
<li>
<a class='clearfix' href='/dockets'>
<div class='navLinkTitle'>
Dockets
</div>
</a>
</li>
<li>
<a class='clearfix' href='/dnds_search'>
<div class='navLinkTitle'>
Domain Name Decisions
</div>
</a>
</li>
<li>
<a class='clearfix' href='/edgar_search'>
<div class='navLinkTitle'>
EDGAR
</div>
</a>
</li>
<li>
<a class='clearfix' href='/clthreads/company-search-clc.php' target='_blank'>
<div class='navLinkTitle'>
EDGAR Comment Threads
</div>
</a>
</li>
</ul>
</td>
<td class=''>
<ul>
<li>
<a class='clearfix' href='/leg_search'>
<div class='navLinkTitle'>
Legislative
</div>
</a>
</li>
<li>
<a class='clearfix' href='/news/advanced_search'>
<div class='navLinkTitle'>
News
</div>
</a>
</li>
<li>
<a class='clearfix' href='/patent_search'>
<div class='navLinkTitle'>
Patents
</div>
</a>
</li>
<li>
<a class='clearfix' href='/people_search'>
<div class='navLinkTitle'>
People
</div>
</a>
</li>
<li>
<a class='clearfix' href='/reg_search'>
<div class='navLinkTitle'>
Regulatory
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/no_action_search'>
<div class='navLinkTitle'>
SEC No-Action Letters
</div>
</a>
</li>
</ul>
</td>
<td class='subNavGutter'></td>
<td class=''>
<ul>
<li>
<a class='clearfix' href='/law_reports'>
<div class='navLinkTitle'>
BNA Law Reports
</div>
</a>
</li>
<li>
<a class='clearfix' href='/nav_content_menu/105.456024'>
<div class='navLinkTitle'>
BNA Manuals
</div>
</a>
</li>
<li>
<a class='clearfix' href='/nav_content_menu/105.456026'>
<div class='navLinkTitle'>
BNA Portfolios
</div>
</a>
</li>
<li>
<a class='clearfix' href='/nav_content_menu/105.102923'>
<div class='navLinkTitle'>
Books & Treatises
</div>
</a>
</li>
<li>
<a class='clearfix' href='/nav_content_menu/105.293113'>
<div class='navLinkTitle'>
Federal Law
</div>
</a>
</li>
<li>
<a class='clearfix' href='/map_nav/laws_regs'>
<div class='navLinkTitle'>
State Law
</div>
</a>
</li>
</ul>
</td>
</tr>
</table>
</div>
<div class='sub_menu subMenu' id='sub_menu_practice_areas'>
<table>
<tr>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/antitrust'>
<div class='navLinkTitle'>
Antitrust
</div>
</a>
</li>
<li>
<a class='clearfix' href='/banking_finance'>
<div class='navLinkTitle'>
Banking & Finance
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/bankruptcy'>
<div class='navLinkTitle'>
Bankruptcy
</div>
</a>
</li>
</ul>
</td>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/corporate_ma'>
<div class='navLinkTitle'>
Corporate/M&A
</div>
</a>
</li>
<li>
<a class='clearfix' href='/employee_benefits'>
<div class='navLinkTitle'>
Employee Benefits
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/health'>
<div class='navLinkTitle'>
Health
</div>
</a>
</li>
</ul>
</td>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/ip_law'>
<div class='navLinkTitle'>
Intellectual Property
</div>
</a>
</li>
<li>
<a class='clearfix' href='/labor_employment'>
<div class='navLinkTitle'>
Labor & Employment
</div>
</a>
</li>
</ul>
</td>
<td class=''>
<ul>
<li>
<a class='clearfix' href='/securities'>
<div class='navLinkTitle'>
Securities
</div>
</a>
</li>
<li>
<a class='clearfix' href='/tax'>
<div class='navLinkTitle'>
Tax
</div>
</a>
</li>
</ul>
</td>
</tr>
</table>
</div>
<div class='sub_menu subMenu' id='sub_menu_LITIGATION'>
<div class='subTitles'>
<div class='subItem two '>
Litigation
</div>
<div class='subItem two last'>
Dockets
</div>
<div class='clearfix'></div>
</div>
<table>
<tr>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/opinion_search'>
<div class='navLinkTitle'>
Search Court Opinions
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/nav_menu/X7TO28O'>
<div class='navLinkTitle'>
BNA Outlines & Headnotes
</div>
</a>
</li>
</ul>
</td>
<td class=''>
<ul>
<li>
<a class='clearfix' href='/nav_content_menu/105.103000'>
<div class='navLinkTitle'>
Federal Rules
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/general'>
<div class='navLinkTitle'>
Litigation Resources
</div>
</a>
</li>
</ul>
</td>
<td class='subNavGutter'></td>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/dockets'>
<div class='navLinkTitle'>
Search Dockets
</div>
</a>
</li>
<li>
<a class='clearfix' href='/dockets/breaking'>
<div class='navLinkTitle'>
Breaking Complaints
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/dockets/analytics'>
<div class='navLinkTitle'>
Docket Analytics
</div>
</a>
</li>
</ul>
</td>
<td class=''>
<ul>
<li>
<a class='clearfix' href='/dockets/coverage'>
<div class='navLinkTitle'>
Docket Coverage
</div>
</a>
</li>
<li>
<a class='clearfix' href='/dockets/requests'>
<div class='navLinkTitle'>
Docket Requests
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/dockets/tracking'>
<div class='navLinkTitle'>
Docket Tracking
</div>
</a>
</li>
</ul>
</td>
</tr>
</table>
</div>
<div class='sub_menu subMenu' id='sub_menu_transactional'>
<div class='subTitles'>
<div class='subItem two '>
Search
</div>
<div class='subItem two last'>
Resources
</div>
<div class='clearfix'></div>
</div>
<table>
<tr>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/edgar_search'>
<div class='navLinkTitle'>
EDGAR
</div>
</a>
</li>
<li>
<a class='clearfix' href='/clthreads/company-search-clc.php' target='_blank'>
<div class='navLinkTitle'>
EDGAR Comment Threads
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/example_and_saved_searches'>
<div class='navLinkTitle'>
Example Searches
</div>
</a>
</li>
</ul>
</td>
<td class=''>
<ul>
<li>
<a class='clearfix' href='/dealmaker_document_search'>
<div class='navLinkTitle'>
DealMaker Documents
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/dealmaker_clause_search'>
<div class='navLinkTitle'>
DealMaker Clauses
</div>
</a>
</li>
</ul>
</td>
<td class='subNavGutter'></td>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/deal_maker/current_awareness'>
<div class='navLinkTitle'>
Current Awareness
</div>
</a>
</li>
<li>
<a class='clearfix' href='/nav_menu/X7TS80O'>
<div class='navLinkTitle'>
Drafting Guides & Overviews
</div>
</a>
</li>
</ul>
</td>
<td class=''>
<ul>
<li>
<a class='clearfix' href='/nav_menu/X7TVS0O'>
<div class='navLinkTitle'>
Transactional Legal Treatises
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/deal_maker/resources'>
<div class='navLinkTitle'>
Transactional Resources
</div>
</a>
</li>
</ul>
</td>
</tr>
</table>
</div>
<div class='sub_menu subMenu' id='sub_menu_LEG_REG'>
<div class='subTitles'>
<div class='subItem two '>
Legislative
</div>
<div class='subItem two last'>
Regulatory
</div>
<div class='clearfix'></div>
</div>
<table>
<tr>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/leg_search'>
<div class='navLinkTitle'>
Search Legislative
</div>
</a>
</li>
<li>
<a class='clearfix' href='/leg_search/congressional_bill_search'>
<div class='navLinkTitle'>
Search Congressional Bills
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/nav_browser/105.24221'>
<div class='navLinkTitle'>
U.S. Code
</div>
</a>
</li>
</ul>
</td>
<td class=''>
<ul>
<li>
<a class='clearfix' href='/map_nav/laws_regs'>
<div class='navLinkTitle'>
State Legislative Materials
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/leg_news_analysis'>
<div class='navLinkTitle'>
Legislative Resources
</div>
</a>
</li>
</ul>
</td>
<td class='subNavGutter'></td>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/reg_search'>
<div class='navLinkTitle'>
Search Regulatory
</div>
</a>
</li>
<li>
<a class='clearfix' href='/reg_search/federal_register_search'>
<div class='navLinkTitle'>
Search Federal Register
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/nav_browser/105.24230'>
<div class='navLinkTitle'>
Code of Federal Regulations
</div>
</a>
</li>
</ul>
</td>
<td class=''>
<ul>
<li>
<a class='clearfix' href='/map_nav/laws_regs'>
<div class='navLinkTitle'>
State Regulatory Materials
</div>
</a>
</li>
<li>
<a class='clearfix' href='/reg_updates'>
<div class='navLinkTitle'>
Monitor Regulators
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/reg_news_analysis'>
<div class='navLinkTitle'>
Regulatory Resources
</div>
</a>
</li>
</ul>
</td>
</tr>
</table>
</div>
<div class='sub_menu subMenu' id='sub_menu_news'>
<div class='subTitles'>
<div class='subItem two '>
Legal Analysis
</div>
<div class='subItem two last'>
News
</div>
<div class='clearfix'></div>
</div>
<table>
<tr>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/law_reports'>
<div class='navLinkTitle'>
BNA Law Reports
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/nav_content_menu/105.456024'>
<div class='navLinkTitle'>
BNA Manuals
</div>
</a>
</li>
</ul>
</td>
<td class=''>
<ul>
<li>
<a class='clearfix' href='/nav_content_menu/105.456026'>
<div class='navLinkTitle'>
BNA Portfolios
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/nav_content_menu/105.102923'>
<div class='navLinkTitle'>
Books & Treatises
</div>
</a>
</li>
</ul>
</td>
<td class='subNavGutter'></td>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/news/advanced_search'>
<div class='navLinkTitle'>
Search News
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/news'>
<div class='navLinkTitle'>
Legal News
</div>
</a>
</li>
</ul>
</td>
<td class=''>
<ul>
<li>
<a class='clearfix' href='/news/topic'>
<div class='navLinkTitle'>
News by Topic
</div>
</a>
</li>
<li>
<a class='clearfix' href='/news/top_news'>
<div class='navLinkTitle'>
TOP News
</div>
</a>
</li>
</ul>
</td>
</tr>
</table>
</div>
<div class='sub_menu subMenu' id='sub_menu_market'>
<table>
<tr>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/business_development'>
<div class='navLinkTitle'>
Business Development Center
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/edgar_search'>
<div class='navLinkTitle'>
Search EDGAR
</div>
</a>
</li>
</ul>
</td>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/company'>
<div class='navLinkTitle'>
Company Watchlist
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/company_search'>
<div class='navLinkTitle'>
Company Screener
</div>
</a>
</li>
</ul>
</td>
<td class='backgroundExtend'>
<ul>
<li class='last'>
<a class='clearfix' href='/report_writer'>
<div class='navLinkTitle'>
Company Report Writer
</div>
</a>
</li>
</ul>
</td>
<td class=''>
<ul>
<li class='last'>
<a class='clearfix' href='/market'>
<div class='navLinkTitle'>
Market News
</div>
</a>
</li>
</ul>
</td>
</tr>
</table>
</div>

</div>
</div>
<div class='bottomFlange'></div>
</div>
<div class='breadcrumbContainer printHide'>
<div class='breadHolder'>
<!-- .breadcrumb -->
<div class='breadcrumb' id='breadcrumb_0'>
Search & Browse
</div>

<div class='breadcrumbDivider'>
/
</div>
<!-- .breadcrumb -->
<div class='breadcrumb' id='breadcrumb_1'>
<a href='/conversion/resolve_search/e1bfb618deb1fc6b1612e3c644864308'>
Court Opinions
</a>
</div>

<div class='breadcrumbDivider'>
/
</div>
<!-- .breadcrumb -->
<div class='breadcrumb' id='breadcrumb_2'>
<a href='/opinion_search/results/e1bfb618deb1fc6b1612e3c644864308'>
Search Results
</a>
</div>

<div class='breadcrumbDivider'>
/
</div>
</div>
</div>

</div>
<div class='page clearfix'>
<div class='content' id='page_content'>
<div id='statusHolder'></div>
<a name='primary_content'></a>
<div class='document_search_links_container printHide'>
<div class='prev_search_result_container'>
<div class='attachmentPanelBackButton' onclick="document.location = $('.prev_search_result_link a').attr('href')"></div>
<div class='prev_search_result_link'>
<a href="/s/opinion/e1bfb618deb1fc6b1612e3c644864308/document/X1IU8PE003?search32=DPNLUQBDE1FN0Q3IC5PMASPT64TJMSRPDPNMSUBDECUJ2" class="{}" data-doc-id="X1IU8PE003">Previous Result: <span>Redding v. Bradshaw, CASE NO. 1:12cv2765...</span></a>
<div class='clearfix'></div>
</div>
</div>
<div class='next_search_result_container'>
<div class='next_search_result_link'>
<a href="/s/opinion/e1bfb618deb1fc6b1612e3c644864308/document/X1IU8PU003?search32=DPNLUQBDE1FN0Q3IC5PMASPT64TJMSRPDPNMSUBDECUJ2" class="{}" data-doc-id="X1IU8PU003">Next Result: <span>Holscher v. U.S. Postal Serv., Case No. ...</span></a>
<div class='clearfix'></div>
</div>
<div class='attachmentPanelForwardButton' onclick="document.location = $('.next_search_result_link a').attr('href')"></div>
</div>
<div class='clearfix'></div>
</div>
<div class='clearfix'></div>

<div class='breadCrumbTitleRow clearfix eight grid'>
<div class="icon citation positive" title="Positive"></div>
<div class='title left' title='Schedin v. Ortho-McNeil-Janssen Pharm., Inc., 700 F.3d 1161 (8th Cir. 2012), Court Opinion'>
Schedin v. Ortho-McNeil-Janssen Pharm., Inc., 700 F.3d 1161 (8th Cir. 2012), Court Opinion
</div>
</div>

<div class='metadata' style='display: none'>
<div class='documentTitle'>Schedin v. Ortho-McNeil-Janssen Pharm., Inc., 700 F.3d 1161 (8th Cir. 2012), Court Opinion</div>
<div class='docId'>X1IU8EM003</div>
<div class='docType'>OPINIONS</div>
<div class='case_name'>Schedin v. Ortho-McNeil-Janssen Pharm., Inc.</div>
<div class='displayCitation'>2012 BL 313391</div>
<div class='displayCitation'>700 F.3d 1161</div>
<div class='displayCitation'>bna a0d5p2k1g7</div>
<div class='displayCitation'>wkf8case:26710251</div>
</div>

<div class='search_outline_node_popup' style='display:none'>
<form accept-charset="UTF-8" action="/document/class_outline_search" id="search_document_node_form" method="post"><div style="margin:0;padding:0;display:inline"><input name="utf8" type="hidden" value="&#x2713;" /><input name="authenticity_token" type="hidden" value="NiJ+70/qv61N1TFnbttr4ZzRa7IGhB5DMvou0CKGUXA=" /></div>
<div class='clearfix popupTitle'>
<div class='close' onclick='closePopup()'></div>
<h2>Search</h2>
</div>
<p class='searchOver'>
Search over:
<span class='search_target_node'></span>
<input class="search_source_id" id="source_id" name="source_id" type="hidden" />
<input class="search_node_id" id="search_node_id" name="search_node_id" type="hidden" />
<input class="search_service_code" id="search_service_code" name="search_service_code" type="hidden" />
<input class="search_division" id="search_division" name="search_division" type="hidden" />
<input autocomplete="off" class="search_node_text" id="search_term" name="search_term" type="text" />
</p>
<div class='clearfix'></div>
<div class='popUpActions'>
<button class='bootstrap skinButton popup action right print' onclick='this.form.submit();'>
<span>
Search
</span>
</button>
<button class='bootstrap skinButton popup cancel right' onclick='closePopup();' type='button'>
<span>
Cancel
</span>
</button>
</div>
</form>

</div>
<div id='no_matching_keywords_popup' style='display:none'>
<div class='popupTitle clearfix'>
<div class='close' onclick='closePopup()'></div>
<h2>No Matches Found</h2>
</div>
<p>
Search term(s) not found.
</p>
<div class='popUpActions'>
<button class='bootstrap skinButton popup cancel right' onclick='closePopup();' type='button'>
<span>
Close
</span>
</button>
</div>
</div>
<div id='copyWithCitationPopupContents' style='display:none'>
<div class='popupTitle clearfix'>
<div class='close' onclick='closePopup()'></div>
<h2>Copy with Citation</h2>
</div>
<p>
Copy the text below to paste into your document.
</p>
<div class='clearfix'>
<div class='copyWithCitationScrollBox'>
<div class='copyWithCitationArea left'>
<div class='copyWithCitationText'></div>
<div class='copyWithCitationDocumentTitle'></div>
</div>
<div class='ie9compat left'>
<img alt="" src="/images/transparency.png?1296705112" width="1" />
</div>
</div>
</div>
<div class='copyWithCitationCheckBoxHolder'>
<input checked="checked" class="linkCitation" id="link_citation" name="link_citation" onclick="updateCopyWithCitationLinks()" type="checkbox" value="true" />
Link citations to Bloomberg Law
</div>
<div class='popUpActions'>
<button class='bootstrap skinButton popup action right' onclick='closePopup();' type='button'>
<span>
Close
</span>
</button>
</div>
</div>

<script type='text/javascript'>
  //<![CDATA[
    $('#page_content').addClass("invisible");
  //]]>
</script>
<input id="doc_id" name="doc_id" type="hidden" value="X1IU8EM003" />
<input id="hidden_document_title" name="hidden_document_title" type="hidden" value="Schedin v. Ortho-McNeil-Janssen Pharm., Inc., 700 F.3d 1161 (8th Cir. 2012), Court Opinion" />
<input id="hidden_case_name" name="hidden_case_name" type="hidden" value="Schedin v. Ortho-McNeil-Janssen Pharm., Inc." />
<input id="hidden_case_docket" name="hidden_case_docket" type="hidden" />
<div class='toolHolder'>
<form accept-charset="UTF-8" action="" id="downloadPopupLinkForm" method="post"><div style="margin:0;padding:0;display:inline"><input name="utf8" type="hidden" value="&#x2713;" /><input name="authenticity_token" type="hidden" value="NiJ+70/qv61N1TFnbttr4ZzRa7IGhB5DMvou0CKGUXA=" /></div><input id="pde_location_type" name="pde_location_type" type="hidden" value="DOCUMENT" /><input id="full_doc_path" name="full_doc_path" type="hidden" value="/s/opinion/e1bfb618deb1fc6b1612e3c644864308/document/X1IU8EM003?search32=DPNLUQBDE1FN0Q3IC5PMASPT64TJMSRPDPNMSUBDECUJ2" /><input id="document_type" name="document_type" type="hidden" value="OPINIONS" /><input id="doc_id" name="doc_id" type="hidden" value="X1IU8EM003&amp;search32=DPNLUQBDE1FN0Q3IC5PMASPT64TJMSRPDPNMSUBDECUJ2" /><input id="artifact_id" name="artifact_id" type="hidden" value="X1IU8EM003" /><input id="title" name="title" type="hidden" value="Schedin v. Ortho-McNeil-Janssen Pharm., Inc., 700 F.3d 1161 (8th Cir. 2012), Court Opinion" /><input id="search32" name="search32" type="hidden" value="DPNLUQBDE1FN0Q3IC5PMASPT64TJMSRPDPNMSUBDECUJ2" /><input id="citation_analysis" name="citation_analysis" type="hidden" value="POSITIVE" /><input id="context_resource_id" name="context_resource_id" type="hidden" value="e1bfb618deb1fc6b1612e3c644864308" /><input id="has_sidebar_info" name="has_sidebar_info" type="hidden" value="true" /><input id="tab_types_" name="tab_types[]" type="hidden" value="TAB_OPINION" /><input id="has_notepad" name="has_notepad" type="hidden" value="true" /><input id="notepad_id" name="notepad_id" type="hidden" value="X1IU8EM003" /><input id="has_headnotes" name="has_headnotes" type="hidden" value="false" /><input id="preselect_option" name="preselect_option" type="hidden" value="DOCUMENT" /></form>

<ul class='tools printHide'>
<li>
<a href="#" onclick="javascript:quickPrintLink(); return false;">Quick Print</a>

</li>
<li>
<a href="#" onclick="javascript:createFormPopupFromForm('download','downloadPopupLinkForm'); return false;">Print/Download</a>
</li>
<li>
<a href="#" onclick="javascript:createFormPopupFromForm('email','downloadPopupLinkForm'); return false;">Email</a>
</li>
<li>
<a href="#" onclick="javascript:addPopupForm('add_to_workspace','?resource_path=%2Fs%2Fopinion%2Fe%31bfb%36%31%38deb%31fc%36b%31%36%31%32e%33c%36%34%34%38%36%34%33%30%38%2Fdocument%2FX%31IU%38EM%30%30%33%3Fsearch%33%32%3DDPNLUQBDE%31FN%30Q%33IC%35PMASPT%36%34TJMSRPDPNMSUBDECUJ%32&amp;document_type=OPINIONS', null); return false;">+ Workspace</a>
</li>
<li>
<a onclick='javascript:PDETray_default.addSelection();'>
+ Queue
</a>
</li>
<li class='last'></li>
</ul>
</div>

<div class='bootstrap printHide tabs'>
<a class='borderTab activeTab' id='tab_DOCUMENT'>
Document
</a>

<a href="/s/opinion/e1bfb618deb1fc6b1612e3c644864308/bcite/X1IU8EM003/history" class="borderTab inactiveTab" id="tab_HISTORY" onclick="docTabSpinner()">Direct History</a>

<a href="/s/opinion/e1bfb618deb1fc6b1612e3c644864308/bcite/X1IU8EM003/analysis" class="borderTab inactiveTab" id="tab_ANALYSIS" onclick="docTabSpinner()">Case Analysis</a>

<a href="/s/opinion/e1bfb618deb1fc6b1612e3c644864308/bcite/X1IU8EM003/toa" class="borderTab inactiveTab" id="tab_TOA" onclick="docTabSpinner()">Table of Authorities</a>

<a href="/s/opinion/e1bfb618deb1fc6b1612e3c644864308/related_content/X1IU8EM003?search32=DPNLUQBDE1FN0Q3IC5PMASPT64TJMSRPDPNMSUBDECUJ2" class="borderTab inactiveTab" id="tab_CITING_DOCS" onclick="docTabSpinner()">Citing Documents</a>

<div class='showHide printHide'>
<div class='showHideSidebarArrow'>
<a class='bliderText' id='bliderLink'>
<span id='bliderText'>
Hide General Info & Notepad
</span>
<span id='notepadCountLabel'></span>
</a>
</div>
</div>

</div>

<!-- document -->
<script type='text/javascript'>
  //<![CDATA[
    var fluid_layout=false;
  //]]>
</script>

<!-- %table.markupContainment -->
<!-- %tbody -->
<!-- %tr -->
<!-- %td#markup_holder{:valign=>"top", :align=>"left"} -->
<div class='docHolder legal hasSearchTerms ' id='doc_holder'>
<div class='documentContent ' id='content_document'>


<script type="text/javascript">
					function Blaw__Citator()
					{
						window.location="bloomberg:bcite_url_prefix=/rest/documents/1750483009539";
					}
				</script><script type="text/javascript">
      var BLAW_TOTAL_KEYWORD = 0;
      var BLAW_CURRENT_KEYWORD = -1;
      var BLAW_LAST_COLOR = "yellow";
      var BLAW_ANCHOR_NAME = "blawkeyword";
      var BLAW_BASE_URL = document.location.href;

      function Blaw__changeCurElem(lastAnchor, newAnchor)
      {
        var baseUrl = Blaw__getBaseURL(document.location.href);
        document.location.href = baseUrl + "#" + newAnchor;
        var elem = document.getElementById(lastAnchor)[0];
        if (elem) {
          elem.style.backgroundColor = BLAW_LAST_COLOR;
        }
        elem = document.getElementById(newAnchor)[0];
        if (elem) {
          BLAW_LAST_COLOR = elem.style.backgroundColor;
          elem.style.backgroundColor = "orange";
        }
      }

      function Blaw__findNextKeyWord()
      {
        var looped = false;
        var lastAnchor = BLAW_ANCHOR_NAME + BLAW_CURRENT_KEYWORD;
        if (++BLAW_CURRENT_KEYWORD >= BLAW_TOTAL_KEYWORD) {
          BLAW_CURRENT_KEYWORD = 0;
        }

        // if index does not exist on page continue to inc until one does
        while(document.getElementById(BLAW_ANCHOR_NAME + BLAW_CURRENT_KEYWORD).length == 0 && BLAW_CURRENT_KEYWORD < BLAW_TOTAL_KEYWORD) {
            ++BLAW_CURRENT_KEYWORD;
            // wrap around search, once only
            if (BLAW_CURRENT_KEYWORD >= BLAW_TOTAL_KEYWORD && !looped) {
              BLAW_CURRENT_KEYWORD = 0;
              looped = true;
            }
        }
        var newAnchor = BLAW_ANCHOR_NAME + BLAW_CURRENT_KEYWORD;
        Blaw__changeCurElem(lastAnchor, newAnchor);
      }

      function Blaw__findPrevKeyWord()
      {
        var looped = false;
        var lastAnchor = BLAW_ANCHOR_NAME + BLAW_CURRENT_KEYWORD;
        if (--BLAW_CURRENT_KEYWORD < 0) {
          BLAW_CURRENT_KEYWORD = BLAW_TOTAL_KEYWORD - 1;
          looped = true;
        }

        // if index does not exist on page continue to decr until one does
        while(document.getElementById(BLAW_ANCHOR_NAME + BLAW_CURRENT_KEYWORD).length == 0 && BLAW_CURRENT_KEYWORD >= 0) {
          --BLAW_CURRENT_KEYWORD;
          // wrap around search, once only
          if (BLAW_CURRENT_KEYWORD < 0 && !looped) {
            BLAW_CURRENT_KEYWORD = BLAW_TOTAL_KEYWORD - 1;
            looped = true;
          }
        }
        var newAnchor = BLAW_ANCHOR_NAME + BLAW_CURRENT_KEYWORD;
        Blaw__changeCurElem(lastAnchor, newAnchor);
      }

      function Blaw__findNextFrom(indx)
      {
        var lastAnchor = BLAW_ANCHOR_NAME + BLAW_CURRENT_KEYWORD;
        BLAW_CURRENT_KEYWORD = indx;
        ++BLAW_CURRENT_KEYWORD;
        if (BLAW_CURRENT_KEYWORD >= BLAW_TOTAL_KEYWORD) {
          BLAW_CURRENT_KEYWORD = 0;
        }
        var newAnchor = BLAW_ANCHOR_NAME + BLAW_CURRENT_KEYWORD;
        Blaw__changeCurElem(lastAnchor, newAnchor);
      }

      function Blaw__getBaseURL(url)
      {
        var reg = new RegExp("(.+)#.+$");
        var ar = reg.exec(url);
        if (ar != null) {
          return ar[1];
        } else {
          return url;
        }
      }


    </script><div xmlns:fo="http://www.w3.org/1999/XSL/Format" class="metadata" style="display: none">
<div class="pagination_series_list">PrimaryFederalReporter,Bloomberg,</div>
<div class="citation-group">
<div class="cite" data-cite-type="PrimaryFederalReporter">700 F.3d 1161</div>
<div class="cite" data-cite-type="DocketNumber">11-3117</div>
<div class="cite" data-cite-type="Bloomberg">2012 BL 313391</div>
</div>
</div>
<div align="left" class="tableofcontents">
<br CLEAR="right"><div class="page_text" style="float:right">
<b>Pagination</b><table class="page_legend" cellspacing="0">
<tr>
<td width="25%" align="left" valign="top">*</td>
<td width="50%" align="left" valign="top">F.3d </td>
</tr>
<tr>
<td width="25%" align="left" valign="top">**</td>
<td width="50%" align="left" valign="top">BL</td>
</tr>
</table>
</div>
<br>
</div>
<table><tbody><tr><td>&nbsp;</td></tr></tbody></table>
<p><center>
United States Court of Appeals, Eighth Circuit.
</center></p>
<hr align="center" width="65%">
<p><center>
In re LEVAQUIN PRODUCTS LIABILITY LITIGATION. John Schedin,
Plaintiff-Appellee v. Ortho-McNeil-Janssen Pharmaceuticals, Inc.,
Defendant-Appellant.
</center></p>
<hr align="center" width="65%">
<p><center>
No. 11-3117.
</center></p>
<p><center>
Submitted: May 17, 2012.
</center></p>
<p><center>
Decided: November 30, 2012. Rehearing and Rehearing En Banc Denied January
23, 2013.<a HREF="#fn*00" name="fnref_fn*00">[fn*]</a>
</center></p>
<p><center>
<span class="fr"><a HREF="#fnref_fn*00" name="fn*00">[fn*]</a></span> Judge Murphy and Judge Bye would grant the petition for rehearing en
banc.
</center></p>
<div id="para2" printdualcolumn="true"><p>
Appeal from the United States District Court for the District of Minnesota,
John R. Tunheim, J.
<span CLASS="page_no" data-cite="700 f 3d 1162" data-cite-type="PrimaryFederalReporter" data-cite-pageno="1162" data-primary-citation="700 F.3d 1161">[*1162]</span> 
[EDITORS' NOTE: THIS PAGE CONTAINED HEADNOTES AND HEADNOTES ARE NOT AN
OFFICIAL PRODUCT OF THE COURT, THEREFORE THEY ARE NOT DISPLAYED.]
</p></div>
<div id="para2" printdualcolumn="true"><p>
<span CLASS="page_no" data-cite="700 f 3d 1163" data-cite-type="PrimaryFederalReporter" data-cite-pageno="1163" data-primary-citation="700 F.3d 1161">[*1163]</span> 
Charles Lifland, argued, Los Angeles, CA, Tracy Joan Van Steenburgh, Dana M.
Lenahan, Minneapolis, MN, John Dames, Chicago, IL, Cynthia Ann Merrill, Los
Angeles, CA, on the brief, for appellant.
</p></div>
<div id="para2" printdualcolumn="true"><p>
Charles M. Wolfson, argued, New York, NY, Ronald S. Goldser, Minneapolis,
MN, Lewis J. Saul, New York, NY, on the brief, for appellee.
</p></div>
<div id="para2" printdualcolumn="true"><p>
Before RILEY, Chief Judge, BYE and MELLOY, Circuit Judges.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
RILEY, Chief Judge.
</p></div>
<div id="contentOpinion" printdualcolumn="true">
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  In 2005, John Schedin suffered Achilles tendon ruptures while taking the
drug Levaquin, which Ortho-McNeil-Janssen Pharmaceuticals, Inc. (OMJP)
markets in the United States. Schedin sued OMJP and others for failing to
warn adequately of the risk of tendon rupture in patients who, like Schedin,
are elderly and taking concomitant corticosteroids. A jury found OMJP
primarily liable, awarding Schedin compensatory and punitive damages. OMJP
appeals the district court's denials of its motions for judgment as a matter
of law (JMOL) and a new trial. We affirm in part and reverse in part.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  <b>I. BACKGROUND</b>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  <b>A. Factual Background</b>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Levofloxacin is a fluoroquinolone antibiotic OMJP marketed in the United
States under the brand name Levaquin.<a HREF="#fn100" name="fnref_fn100">[fn1]</a> In February 2005, Dr. John
Beecher prescribed both Levaquin and a corticosteroid to Schedin, who was
then seventy-six years old. Schedin suffered a rupture of his left Achilles
tendon and a partial tear of his right Achilles tendon after taking the drug
combination.
</p></div>
<span CLASS="page_no" data-cite="700 f 3d 1164" data-cite-type="PrimaryFederalReporter" data-cite-pageno="1164" data-primary-citation="700 F.3d 1161">[*1164]</span> <div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  At that time, Levaquin's package insert warned, in relevant part:
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
      <b>Tendon effects:</b> Ruptures of the . . . Achilles tendon . . . that
    required surgical repair or resulted in prolonged disability have
    been reported in patients receiving quinolones, including
    [Levaquin]. Post-marketing surveillance reports indicate that this
    risk may be increased in patients receiving concomitant
    corticosteroids, especially in the elderly.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
The warning had been largely in this form since 2001, when OMJP voluntarily
added the second sentence. In 2004, the United States Food and Drug
Administration (FDA) made this language mandatory for all
fluoroquinolones.<a HREF="#fn200" name="fnref_fn200">[fn2]</a>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The Levaquin package insert consisted of over fifteen pages of small print
information about the drug, including its proper use and possible side
effects. The tendon warning appears in the last of the ten paragraphs in the
"Warnings" section. The package insert also contained sections titled
"Contraindications," "Precautions," and "Adverse Reactions," among others.
The tendon warning from Levaquin's package insert also appeared in the
Physicians' Desk Reference (PDR), a common medical publication that contains
label information about numerous drugs.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The tendon warning remained largely unchanged between 2001 and 2008. In
2008, the FDA sent OMJP a letter directing OMJP to set off Levaquin's tendon
warning in a black box because the 2001 warning was inadequate (2008
letter). In the 2008 letter, the FDA expressed concern about the large
number of adverse event reports about tendon injuries it continued <span CLASS="page_no" data-cite="2012 bl 313391 p 2" data-cite-type="Bloomberg" data-cite-pageno="2" data-primary-citation="">[**2]</span> to
receive, despite the tendon warnings required for fluoroquinolones as a
class. The FDA concluded, based upon its new analysis of such reports, "the
current Levaquin labeling does not adequately warn healthcare providers and
patients." OMJP had access to all adverse event reports relating to
Levaquin.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  In 2002, the United Kingdom Medicines Control Agency (MCA) issued a report
linking Levaquin to a greater incidence of tendon injuries than other
fluoroquinolones. The MCA recommended reviewing data from the United States
to determine whether that data supported this conclusion. An OMJP affiliate
sponsored a study (Ingenix study) in 2002 that concluded Levaquin did not
materially increase the risk of tendon rupture more than other
fluoroquinolones.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  In addition to package inserts, drug companies communicate with physicians
about their products using the PDR, inperson visits by sales
representatives, "Dear Doctor" letters sent to individual physicians, and
other methods. One article suggested properly worded and highly publicized
"Dear Doctor" letters may contribute to reducing undesirable prescribing
practices.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Dr. Beecher testified he learns about drug side effects from package
inserts, a summary of the PDR, medical literature, sales representatives,
and his colleagues. Dr. Beecher testified he prescribes 250 to 300 drugs in
his practice and does not have enough time to check all package inserts for
changes to the warnings. He reported relying on sales representatives "only
minimally," saying he "probably relie[s] on drug reps more than [he]
think[s]," but tries "very hard to be objective." Dr. Beecher noted he would
have appreciated having more knowledge about the risk of
<span CLASS="page_no" data-cite="700 f 3d 1165" data-cite-type="PrimaryFederalReporter" data-cite-pageno="1165" data-primary-citation="700 F.3d 1161">[*1165]</span> 
prescribing Levaquin and a corticosteroid together.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Though Dr. Beecher knew of the risk of tendon rupture associated with
Levaquin, he did not read and was not aware of the 2001 warning, regarding
elderly patients taking corticosteroids, when he prescribed Levaquin to
Schedin. OMJP did not send a "Dear Doctor" letter about the 2001 warning,
and there is no evidence OMJP's sales representatives attempted to
communicate that warning personally to Dr. Beecher. Monica Sadar, an OMJP
sales representative who visited Dr. Beecher several times per year,
testified (1) her practice was "to discuss package insert changes with all
practitioners," but she did not specifically remember discussing the 2001
warning with Dr. Beecher; (2) her notes from meetings with Dr. Beecher do
not indicate such a discussion; and (3) the Levaquin sales aids she used did
not mention the risk of tendon rupture.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Dr. Beecher testified he would not have prescribed Levaquin to Schedin if
he had known about the 2001 warning or what he knows now. Dr. Beecher also
stated he no longer prescribes Levaquin unless a patient specifically
requests it.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  <b>B. Procedural History</b>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Schedin sued OMJP in federal district court, properly invoking the court's
diversity jurisdiction. <i>See</i><a href="/s/opinion/e1bfb618deb1fc6b1612e3c644864308/document/XEIMUQ003?jcsearch=28%20U.S.C.%20%201332&amp;summary=yes#jcite">28 U.S.C. &sect; 1332</a>. Schedin alleged he was injured
by OMJP's failure to warn Schedin and Dr. Beecher sufficiently about the
risk <span CLASS="page_no" data-cite="2012 bl 313391 p 3" data-cite-type="Bloomberg" data-cite-pageno="3" data-primary-citation="">[**3]</span> of tendon rupture in elderly patients taking Levaquin and concomitant
corticosteroids.<a HREF="#fn300" name="fnref_fn300">[fn3]</a> Schedin claimed OMJP negligently failed to (1) take
adequate steps to alert doctors to the information in the 2001 warning, and
(2) warn of Levaquin's tendon toxicity relative to other fluoroquinolones.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  After a jury found OMJP primarily liable, awarding Schedin compensatory
damages of $630,000 (after reducing the overall assessment of damages by 15%
due to Dr. Beecher's contributing fault) and punitive damages of $1,115,000,
OMJP moved for JMOL and a new trial. OMJP appeals from the district court's
denial of OMJP's motions. We have jurisdiction under <a href="/s/opinion/e1bfb618deb1fc6b1612e3c644864308/document/XEIMU8003?jcsearch=28%20U.S.C.%20%201291&amp;summary=yes#jcite">28 U.S.C. &sect; 1291</a>.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  <b>II. DISCUSSION</b>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  <b>A. Applicable Law and Standard of Review</b>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  We apply Minnesota law to Schedin's failure-to-warn claim.<a HREF="#fn400" name="fnref_fn400">[fn4]</a><i>See</i>
<i>Winthrop Res. Corp. v. Stanley Works</i>, <a href="/s/opinion/e1bfb618deb1fc6b1612e3c644864308/document/X512OB?jcsearch=259%20f%203d%20901&amp;summary=yes#jcite">259 F.3d 901</a>, <a href="/s/opinion/e1bfb618deb1fc6b1612e3c644864308/document/X512OB?jcsearch=259%20f%203d%20901&amp;summary=yes#jcite">904</a> (8th Cir.2001) ("As
a federal court sitting in diversity jurisdiction, we apply the law that the
forum state would apply."). In addition, "[w]hen federal jurisdiction is
premised on diversity of citizenship, a federal district court applies the
sufficiency standards of the state in which it sits," in this case
Minnesota. <i>Carpenter v. Auto. Club Interinsurance Exch.</i>, <a href="/s/opinion/e1bfb618deb1fc6b1612e3c644864308/document/X30F9I?jcsearch=58%20f%203d%201296&amp;summary=yes#jcite">58 F.3d 1296</a>, <a href="/s/opinion/e1bfb618deb1fc6b1612e3c644864308/document/X30F9I?jcsearch=58%20f%203d%201296&amp;summary=yes#jcite">1301</a>
(8th Cir.1995).
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  A district court must grant JMOL if "there is no legally sufficient
evidentiary basis for a reasonable jury to find for [the non-moving] party."
<a href="/s/opinion/e1bfb618deb1fc6b1612e3c644864308/document/X133S74003?jcsearch=MNCIVPRO%2050.01&amp;summary=yes#jcite">Minn. R. Civ. P. 50.01(a)</a>; <i>see</i> <a href="/s/opinion/e1bfb618deb1fc6b1612e3c644864308/document/X133S76003?jcsearch=MNCIVPRO%2050.02&amp;summary=yes#jcite">Minn. R. Civ. P. 50.02</a> (concerning renewed
motions for judgment as a matter of law). We review de novo the district
court's denial of JMOL. <i>See Weber v. Strippit, Inc.</i>, <a href="/s/opinion/e1bfb618deb1fc6b1612e3c644864308/document/X4VTS6?jcsearch=186%20f%203d%20907&amp;summary=yes#jcite">186 F.3d 907</a>, <a href="/s/opinion/e1bfb618deb1fc6b1612e3c644864308/document/X4VTS6?jcsearch=186%20f%203d%20907&amp;summary=yes#jcite">912</a> (8th
Cir.1999).
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<span CLASS="page_no" data-cite="700 f 3d 1166" data-cite-type="PrimaryFederalReporter" data-cite-pageno="1166" data-primary-citation="700 F.3d 1161">[*1166]</span> 
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The standard for granting a new trial is "less rigorous than the standard
for granting" JMOL. <i>Clifford v. Geritom Med, Inc.</i>, <a href="/s/opinion/e1bfb618deb1fc6b1612e3c644864308/document/XAU8L1?jcsearch=681%20north%20western%202d%20680&amp;summary=yes#jcite">681 N.W.2d 680</a>, <a href="/s/opinion/e1bfb618deb1fc6b1612e3c644864308/document/XAU8L1?jcsearch=681%20north%20western%202d%20680&amp;summary=yes#jcite">687</a>
(Minn.2004). A new trial is merited when "the verdict is so contrary to the
preponderance of the evidence as to imply that the jury failed to consider
all the evidence, or acted under some mistake." <i><a href="/s/opinion/e1bfb618deb1fc6b1612e3c644864308/document/XAU8L1?jcsearch=681%20N.W.2d%20680&amp;summary=yes#jcite">Id</a>.</i> (quoting <i>LaValle v.</i>
<i>Aqualand Pool Co.</i>, <a href="/s/opinion/e1bfb618deb1fc6b1612e3c644864308/document/X3RU98?jcsearch=257%20north%20western%202d%20324&amp;summary=yes#jcite">257 N.W.2d 324</a>, <a href="/s/opinion/e1bfb618deb1fc6b1612e3c644864308/document/X3RU98?jcsearch=257%20north%20western%202d%20324&amp;summary=yes#jcite">328</a> (Minn.1977)) (internal marks
omitted); see also Minn. R. Civ. P. 59.01(g). We review the district court's
denial of "a new trial for a clear abuse of discretion." <i>Harrison v. Purdy</i>
<i>Bros. Trucking Co.</i>, <a href="/s/opinion/e1bfb618deb1fc6b1612e3c644864308/document/XADUQP?jcsearch=312%20f%203d%20346&amp;summary=yes#jcite">312 F.3d 346</a>, <a href="/s/opinion/e1bfb618deb1fc6b1612e3c644864308/document/XADUQP?jcsearch=312%20f%203d%20346&amp;summary=yes#jcite">351</a> (8th Cir.2002) (quoting <i>Duty v.</i>
<i>Norton-Alcoa Proppants</i>, 293' F.3d 481, 495 (8th Cir.2002)) (internal
quotation marks omitted).
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  <b>B. Failure to Warn</b>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Schedin presents two theories of failure-to-warn liability, alleging OMJP
negligently failed to (1) use adequate means to inform Dr. Beecher of the
2001 warning against use of Levaquin with elderly patients on
corticosteroids, and (2) include comparative tendon toxicity information in
the package insert. Because OMJP was not entitled to JMOL or a new trial in
light of Schedin's first theory, we need not address whether the district
court erred in denying OMJP's motions based upon Schedin's comparative
toxicity theory because any such error was harmless &mdash; Schedin was entitled
to compensatory damages based on the first theory, even if the district
court erred as to the comparative toxicity theory. <i>Cf. Thomlison v. City of</i>
<i>Omaha</i>, <a href="/s/opinion/e1bfb618deb1fc6b1612e3c644864308/document/X53NQU?jcsearch=63%20f%203d%20786&amp;summary=yes#jcite">63 F.3d 786</a>, <a href="/s/opinion/e1bfb618deb1fc6b1612e3c644864308/document/X53NQU?jcsearch=63%20f%203d%20786&amp;summary=yes#jcite">791</a> (8th Cir.1995) (determining any error in granting
JMOL on certain claims was harmless where the "the district court's judgment
[on plaintiff-appellant's other claim] preserved her full monetary and <span CLASS="page_no" data-cite="2012 bl 313391 p 4" data-cite-type="Bloomberg" data-cite-pageno="4" data-primary-citation="">[**4]</span> other
relief).
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  A plaintiff asserting a negligent failure-to-warn claim under Minnesota
law "must show: (1) the defendant[] had reason to know of the dangers of
using the product; (2)`the warnings fell short of those reasonably
required,' breaching the duty of care; and (3) the lack of an adequate
warning caused the plaintiffs injuries." <i>Tuttle v. Lorillard Tobacco Co.</i>,
<a href="/s/opinion/e1bfb618deb1fc6b1612e3c644864308/document/XEK6UB?jcsearch=377%20f%203d%20917&amp;summary=yes#jcite">377 F.3d 917</a>, <a href="/s/opinion/e1bfb618deb1fc6b1612e3c644864308/document/XEK6UB?jcsearch=377%20f%203d%20917&amp;summary=yes#jcite">924</a> (8th Cir.2004) (quoting <i>Erickson ex rel. Bunker v. Am.</i>
<i>Honda Motor Co.</i>, <a href="/s/opinion/e1bfb618deb1fc6b1612e3c644864308/document/X2T990?jcsearch=455%20north%20western%202d%2074&amp;summary=yes#jcite">455 N.W.2d 74</a>, <a href="/s/opinion/e1bfb618deb1fc6b1612e3c644864308/document/X2T990?jcsearch=455%20north%20western%202d%2074&amp;summary=yes#jcite">77</a> (Minn.Ct.App.1990)). "[T]he existence of
a duty to warn is a" question of law. <i>Balder v. Haley</i>, <a href="/s/opinion/e1bfb618deb1fc6b1612e3c644864308/document/X2SKU9?jcsearch=399%20north%20western%202d%2077&amp;summary=yes#jcite">399 N.W.2d 77</a>, <a href="/s/opinion/e1bfb618deb1fc6b1612e3c644864308/document/X2SKU9?jcsearch=399%20north%20western%202d%2077&amp;summary=yes#jcite">81</a>
(Minn.1987). Under the learned intermediary doctrine,<a HREF="#fn500" name="fnref_fn500">[fn5]</a> as adopted in
Minnesota, prescription drug manufacturers can satisfy their duty to warn by
warning prescribing physicians of the risks associated with a drug, rather
than warning patients directly. <i>See Mulder</i>, <a href="/s/opinion/e1bfb618deb1fc6b1612e3c644864308/document/X2RJ3U?jcsearch=181%20north%20western%202d%20882&amp;summary=yes#jcite">181 N.W.2d at 885</a> &amp; n. 1.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  OMJP does not dispute it had notice of the risk of tendon rupture in
elderly patients taking concomitant corticosteroids. The parties debate
whether OMJP's warning and the means of communicating that warning were
adequate, and, if not, whether any inadequacy caused Schedin's injury.
Because OMJP's arguments for JMOL and a new trial on Schedin's failure to
warn claim are substantially similar, we address the district court's
rulings on OMJP's motions together.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<span CLASS="page_no" data-cite="700 f 3d 1167" data-cite-type="PrimaryFederalReporter" data-cite-pageno="1167" data-primary-citation="700 F.3d 1161">[*1167]</span> 
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  <b>1. Inadequate Communication of 2001 Warning</b>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The district court denied OMJP's motion for a new trial, finding the
jury's verdict that OMJP did not adequately communicate the 2001 warning to
Dr. Beecher was not against the great weight of the evidence and thus was
not a miscarriage of justice under Minnesota law.<a HREF="#fn600" name="fnref_fn600">[fn6]</a> Though OMJP changed
the tendon warning in the package insert, there is just enough evidence to
support a reasonable jury finding OMJP did not use sufficient means, under
the circumstances of this case, to advise Dr. Beecher of the 2001 warning
once OMJP learned the package insert was ineffective.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Courts disagree about whether simply changing the package insert warnings
insulates a drug manufacturer from failure-to-warn liability, and Minnesota
courts have not decided this issue. Many courts considering the question
have held a properly worded package insert is a sufficient warning as a
matter of law, at least when it is combined with an entry in the PDR. <i>See,</i>
<i>e.g., Foister v. Purdue Pharma., L.P.</i>, <a href="/s/opinion/e1bfb618deb1fc6b1612e3c644864308/document/XADTIS?jcsearch=295%20f%20supp%202d%20693&amp;summary=yes#jcite">295 F.Supp.2d 693</a>, <a href="/s/opinion/e1bfb618deb1fc6b1612e3c644864308/document/XADTIS?jcsearch=295%20f%20supp%202d%20693&amp;summary=yes#jcite">705-08</a>
(E.D.Ky.2003); <i>MacPherson v. Searle &amp; Co.</i>, <a href="/s/opinion/e1bfb618deb1fc6b1612e3c644864308/document/X462JQ?jcsearch=775%20f%20supp%20417&amp;summary=yes#jcite">775 F.Supp. 417</a>, <a href="/s/opinion/e1bfb618deb1fc6b1612e3c644864308/document/X462JQ?jcsearch=775%20f%20supp%20417&amp;summary=yes#jcite">425</a>
(D.D.C.1991); <i>Weinberger v. Bristol-Myers Co.</i>, <a href="/s/opinion/e1bfb618deb1fc6b1612e3c644864308/document/X456JF?jcsearch=652%20f%20supp%20187&amp;summary=yes#jcite">652 F.Supp. 187</a>, <a href="/s/opinion/e1bfb618deb1fc6b1612e3c644864308/document/X456JF?jcsearch=652%20f%20supp%20187&amp;summary=yes#jcite">190</a>
(D.Md.1986); <i>Dunkin v. Syntex Labs., Inc.</i>, <a href="/s/opinion/e1bfb618deb1fc6b1612e3c644864308/document/X4J928?jcsearch=443%20f%20supp%20121&amp;summary=yes#jcite">443 F.Supp. 121</a>, <a href="/s/opinion/e1bfb618deb1fc6b1612e3c644864308/document/X4J928?jcsearch=443%20f%20supp%20121&amp;summary=yes#jcite">124</a>
(W.D.Tenn.1977). On the other hand, applying South Dakota law, our court
concluded, "when the dangers of the prolonged use of [a] drug . . . became
reasonably apparent, it was not unreasonable to find that the [manufacturer]
should have employed all its usual means of communication, including [sales
representatives], to warn the prescribing physicians of these dangers."
<i>Sterling Drug, Inc. v. Yarrow</i>, <a href="/s/opinion/e1bfb618deb1fc6b1612e3c644864308/document/X3GR53?jcsearch=408%20f%202d%20978&amp;summary=yes#jcite">408 F.2d 978</a>, <a href="/s/opinion/e1bfb618deb1fc6b1612e3c644864308/document/X3GR53?jcsearch=408%20f%202d%20978&amp;summary=yes#jcite">992</a> (8th Cir.1969). We do not
address this split by deciding the issue as a matter of law because, on the
narrow facts of this case, there was sufficient evidence for a reasonable
jury to find OMJP should have known that the package insert and PDR warnings
were not adequately communicating the 2001 warning to physicians.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The 2001 warning <span CLASS="page_no" data-cite="2012 bl 313391 p 5" data-cite-type="Bloomberg" data-cite-pageno="5" data-primary-citation="">[**5]</span> added a sentence to the last paragraph of the ten
paragraph "Warnings" section of the package insert. It was surrounded by
more than fifteen pages of other small print. More importantly, the FDA's
2008 letter indicates the FDA received a large number of reports about
tendon injuries related to Levaquin use. The jury could infer at least some
of the reports were made between 2001 and Schedin's 2005 prescription and
injury. OMJP had access to these adverse event reports. From this evidence,
a reasonable jury could find OMJP should have realized the adverse event
reports indicated physicians were unaware of the 2001 warning. The district
court did not abuse its discretion in deciding it was not against the
preponderance of the evidence or a miscarriage of justice under Minnesota
law for the jury to find OMJP had reason to know it needed to do more to
inform physicians of the 2001 warning, such as sending "Dear Doctor" letters
or directing sales representatives to warn physicians directly. The district
court properly denied JMOL for the same reasons.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  OMJP maintains the district court erred in admitting the 2008 FDA letter
into evidence because OMJP "cannot be liable for knowledge [OMJP] could not
have possessed until later." OMJP argues the letter contains such
later-acquired information because (1) the FDA can require
<span CLASS="page_no" data-cite="700 f 3d 1168" data-cite-type="PrimaryFederalReporter" data-cite-pageno="1168" data-primary-citation="700 F.3d 1161">[*1168]</span> 
label changes based only on new information; and (2) most of the events to
which the letter refers must have occurred after Schedin's February 2005
injury because the 2008 letter "emphasized reliance on adverse event reports
received after the" FDA approved the revised tendon warning for all
fluoroquinolones in 2004.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  As discussed above, the 2008 letter provides some corroboration of the
probability OMJP had some knowledge of the adverse event reports before
Schedin's injury in February 2005. Although the FDA must notify drug
manufacturers of "new safety information that the Secretary believes should
be included in" a drug label, <a href="/s/opinion/e1bfb618deb1fc6b1612e3c644864308/document/XEI5OQ003?jcsearch=21%20U.S.C.%20%20355(o)(4)&amp;summary=yes#jcite">21 U.S.C. &sect; 355</a>(o)(4), nothing in the
definition of "new safety information" excludes information that was known
or knowable before a label change, <i>see</i><a href="/s/opinion/e1bfb618deb1fc6b1612e3c644864308/document/X17R3NG003?jcsearch=21%20U.S.C.%20%20355-1(b)(3)&amp;summary=yes#jcite">21 U.S.C. &sect; 355-1</a>(b)(3). In fact, such
information "may be based on a new analysis of information that existed when
the FDA initially approved a drug. <a href="/s/opinion/e1bfb618deb1fc6b1612e3c644864308/document/X17R3NG003?jcsearch=21%20U.S.C.%20%20355-1(b)(3)(A)&amp;summary=yes#jcite">21 U.S.C. &sect; 355-1</a>(b)(3)(A). The jury
reasonably could have found some reports were made before Schedin's 2005
injury. The district court could have found the letter inadmissible, but did
not abuse its considerable discretion in admitting the FDA's 2008 letter.
<i>See Der v. Connolly</i>, <a href="/s/opinion/e1bfb618deb1fc6b1612e3c644864308/document/X1H136G003?jcsearch=666%20f%203d%201120&amp;summary=yes#jcite">666 F.3d 1120</a>, <a href="/s/opinion/e1bfb618deb1fc6b1612e3c644864308/document/X1H136G003?jcsearch=666%20f%203d%201120&amp;summary=yes#jcite">1130-31</a> (8th Cir.2012) (standard of
review).
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  <b>2. Causation</b>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Although, generally, "[w]here warning is given, <i>the seller may reasonably</i>
<i>assume that it will be read and heeded," J &amp; W Enters., Inc. v. Economy</i>
<i>Sales, Inc.</i>, <a href="/s/opinion/e1bfb618deb1fc6b1612e3c644864308/document/X2TDM1?jcsearch=486%20north%20western%202d%20179&amp;summary=yes#jcite">486 N.W.2d 179</a>, <a href="/s/opinion/e1bfb618deb1fc6b1612e3c644864308/document/X2TDM1?jcsearch=486%20north%20western%202d%20179&amp;summary=yes#jcite">181</a> (Minn.Ct.App.1992) (emphasis in <i>J &amp; W</i>
<i>Enters., Inc.</i>) (quoting <i>Restatement (Second) of Torts</i> <cite>&sect; 402A</cite>, cmt. j (1965))
(internal quotation marks omitted), failure to read a warning does not
necessarily bar recovery where, as here, the plaintiff claims inadequate
communication of the warning caused the failure to read it. <i>Cf. Johnson v.</i>
<i>Niagara Mach. &amp; Tool Works</i>, <a href="/s/opinion/e1bfb618deb1fc6b1612e3c644864308/document/X3PAJQ?jcsearch=666%20f%202d%201223&amp;summary=yes#jcite">666 F.2d 1223</a>, <a href="/s/opinion/e1bfb618deb1fc6b1612e3c644864308/document/X3PAJQ?jcsearch=666%20f%202d%201223&amp;summary=yes#jcite">1225-26</a> &amp; n. 3 (8th Cir.1981)
(applying Minnesota law on <span CLASS="page_no" data-cite="2012 bl 313391 p 6" data-cite-type="Bloomberg" data-cite-pageno="6" data-primary-citation="">[**6]</span> a failure to warn claim, affirming the district
court's grant of a directed verdict for the defendant because the plaintiff
had not read the warning, and leaving open the possibility of a different
result if the plaintiff had claimed the warning's form was inadequate). To
prove causation in a Minnesota failure to warn case, it is sufficient to
present testimony that purchasers would have avoided the risk of harm had
they been told of the relevant danger. <i>See Erickson</i>, <a href="/s/opinion/e1bfb618deb1fc6b1612e3c644864308/document/X2T990?jcsearch=455%20north%20western%202d%2074&amp;summary=yes#jcite">455 N.W.2d at 78</a>.
Because the learned intermediary doctrine applies, OMJP had a duty to warn
Dr. Beecher, rather than warning Schedin directly, <i>see Mulder</i>,
<a href="/s/opinion/e1bfb618deb1fc6b1612e3c644864308/document/X2RJ3U?jcsearch=181%20north%20western%202d%20882&amp;summary=yes#jcite">181 N.W.2d at 885</a> &amp; n. 1, and the principle of <i>Erickson</i> should apply with
equal force in the learned intermediary doctrine context.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The district court found sufficient evidence of causation, reasoning "the
jury could infer from the fact that [Dr.] Beecher no longer prescribes
Levaquin that <b>some</b> piece of information would have altered his prescribing
decision since, in fact, he has changed his prescribing patterns as a result
of his increased awareness of the risks of the drug." Dr. Beecher testified
he no longer prescribes Levaquin unless a patient requests it. Even more to
the point, Dr. Beecher declared he would not have prescribed Levaquin for
Schedin had Dr. Beecher been aware of the 2001 warning and known what he
knows now. <i>See Erickson</i>, <a href="/s/opinion/e1bfb618deb1fc6b1612e3c644864308/document/X2T990?jcsearch=455%20north%20western%202d%2074&amp;summary=yes#jcite">455 N.W.2d at 78</a>.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  OMJP argues Schedin did not prove causation because Dr. Beecher spends
little time with sales representatives and did not testify he read or relied
on "Dear Doctor" letters. We disagree. Dr. Beecher stated he relies on sales
representatives "only minimally" and tries "very hard to
<span CLASS="page_no" data-cite="700 f 3d 1169" data-cite-type="PrimaryFederalReporter" data-cite-pageno="1169" data-primary-citation="700 F.3d 1161">[*1169]</span> 
be objective." This reasonably can be interpreted as meaning Dr. Beecher did
not rely heavily on sales representatives' promotional efforts &mdash; not that he
would have ignored a warning &mdash; especially because Dr. Beecher said he would
have appreciated having more knowledge about this particular side effect.
Also, there is general study evidence indicating properly worded and highly
publicized "Dear Doctor" letters may reduce risky prescribing practices.
Although Dr. Beecher did not specifically testify he relies on "Dear Doctor"
letters, physicians reportedly receive and rely on information about drug
warnings from such letters. Dr. Beecher did testify he relies on his
colleagues' comments about particular drugs. Although a stretch, the jury
reasonably could infer Dr. Beecher would have learned about the changed
warning if OMJP warned Dr. Beecher or his colleagues using sales
representatives or publicized "Dear Doctor" letters. The district court did
not abuse its discretion in holding such a jury finding was not against the
preponderance of the evidence.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The district court did not err in denying OMJP's motions for JMOL or a new
trial based on the jury's award of compensatory damages.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  <b>C. Punitive Damages</b>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Under Minnesota law, punitive damages are "allowed in civil actions only
upon clear and convincing evidence" the defendant "deliberate[ly]
disregard[ed]. . . the rights or safety of others." Minn.Stat. &sect; <a href="/s/opinion/e1bfb618deb1fc6b1612e3c644864308/document/XEUQMK003?jcsearch=Minn.%20Stat.%20%20549.20(1)(a)&amp;summary=yes#jcite">549.20</a>
subd. 1(a). This means the defendant <span CLASS="page_no" data-cite="2012 bl 313391 p 7" data-cite-type="Bloomberg" data-cite-pageno="7" data-primary-citation="">[**7]</span> knew of "or intentionally disregard[ed]
facts that create a high probability of injury to the rights or safety of
others and . . . deliberately proceed[ed] to act in conscious or intentional
disregard . . . or . . . with indifference to" that probability. Minn.Stat.
&sect; <a href="/s/opinion/e1bfb618deb1fc6b1612e3c644864308/document/XEUQMK003?jcsearch=Minn.%20Stat.%20%20549.20(1)(b)&amp;summary=yes#jcite">549.20</a> subd. 1(b). Punitive damages are appropriate where the defendant
"did not merely fail to act, but . . . continued to market a product which
was so mislabeled so as to mislead the public into believing that" the
hazard did not exist. <i>Olson v. Snap Prods., Inc.</i>, <a href="/s/opinion/e1bfb618deb1fc6b1612e3c644864308/document/X3VEOM?jcsearch=29%20f%20supp%202d%201027&amp;summary=yes#jcite">29 F.Supp.2d 1027</a>, <a href="/s/opinion/e1bfb618deb1fc6b1612e3c644864308/document/X3VEOM?jcsearch=29%20f%20supp%202d%201027&amp;summary=yes#jcite">1039</a>
(D.Minn.1998). Punitive damages require "a maliciousness, an intentional or
willful failure to inform or act," and are not proper where the defendant
"actively sought ways to prevent the dangers associated with its product."
<i>Beniek v. Textron, Inc.</i>, <a href="/s/opinion/e1bfb618deb1fc6b1612e3c644864308/document/X2TC89?jcsearch=479%20north%20western%202d%20719&amp;summary=yes#jcite">479 N.W.2d 719</a>, <a href="/s/opinion/e1bfb618deb1fc6b1612e3c644864308/document/X2TC89?jcsearch=479%20north%20western%202d%20719&amp;summary=yes#jcite">723</a> (Minn.Ct.App.1992).
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The district court upheld the jury's award of punitive damages because of
evidence OMJP "knew of the potential for the higher tendon toxicity of
Levaquin, assisted in the design of [the Ingenix study,] allegedly to hide
that potential and cloud the field of academic literature on the topic, and
then failed to adequately warn prescribers." (internal citations omitted).
On this record, this motive allegation is mere speculation.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  As a matter of law, the record evidence failed to establish OMJP
deliberately disregarded the risk of tendon injuries in elderly patients
taking corticosteroids, as required for punitive damages under Minnesota
law. By warning of that risk in its package insert, OMJP "actively sought
ways to prevent the dangers associated with its product." <i>Beniek</i>,
<a href="/s/opinion/e1bfb618deb1fc6b1612e3c644864308/document/X2TC89?jcsearch=479%20north%20western%202d%20719&amp;summary=yes#jcite">479 N.W.2d at 723</a>. The 2001 warning also was published in the PDR, a
reference widely used by physicians. Regardless of OMJP's alleged actions
relating to the Ingenix study, we cannot characterize OMJP as hiding
information it openly published. The 2001 warning was in Dr. Beecher's
physical possession and was specific and clear if read. For drug warnings to
succeed in protecting patients, doctors must order their practice and their
continuing medical education so as to find time to learn about new
<span CLASS="page_no" data-cite="700 f 3d 1170" data-cite-type="PrimaryFederalReporter" data-cite-pageno="1170" data-primary-citation="700 F.3d 1161">[*1170]</span> 
and updated warnings for the drugs the doctor is prescribing.<a HREF="#fn700" name="fnref_fn700">[fn7]</a>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The evidence is neither clear nor convincing, as a matter of law, that
OMJP deliberately disregarded the safety of the users of Levaquin. The
district court erred in denying JMOL for OMJP on punitive damages.<a HREF="#fn800" name="fnref_fn800">[fn8]</a>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  <b>III. CONCLUSION</b>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  We affirm in part and reverse in part. We affirm the district court's
denial of OMJP's motions for JMOL or a new trial on Schedin's claim for
compensatory damages, and reverse the denial of OMJP's motion for JMOL on
punitive damages.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<span class="fr"><a HREF="#fnref_fn100" name="fn100">[fn1]</a></span> Levofloxacin is marketed under other names elsewhere. We refer to
levofloxacin as "Levaquin" throughout this opinion for consistency.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<span class="fr"><a HREF="#fnref_fn200" name="fn200">[fn2]</a></span> We refer to the 2001 and 2004 warning labels collectively as the "2001
warning" because the FDA's 2004 requirement did not substantially change the
2001, language about corticosteroids and the elderly.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<span class="fr"><a HREF="#fnref_fn300" name="fn300">[fn3]</a></span> Schedin asserted other claims against OMJP, OMJP's parent company,
Johnson &amp; Johnson, and another affiliate that are not at issue in this
appeal.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<span class="fr"><a HREF="#fnref_fn400" name="fn400">[fn4]</a></span> Neither party disputes the district court's application of Minnesota
law.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<span class="fr"><a HREF="#fnref_fn500" name="fn500">[fn5]</a></span> The learned intermediary doctrine provides that a drug "manufacturer
has no duty to warn the lay public regarding prescription drugs," but rather
must warn the prescribing physician. <i>Mulder v. Parke Davis &amp; Co.</i>,
<a href="/s/opinion/e1bfb618deb1fc6b1612e3c644864308/document/X2RJ3U?jcsearch=288%20minnesota%20332&amp;summary=yes#jcite">288 Minn. 332</a>, <a href="/s/opinion/e1bfb618deb1fc6b1612e3c644864308/document/X2RJ3U?jcsearch=181%20north%20western%202d%20882&amp;summary=yes#jcite">181 N.W.2d 882</a>, <a href="/s/opinion/e1bfb618deb1fc6b1612e3c644864308/document/X2RJ3U?jcsearch=181%20north%20western%202d%20882&amp;summary=yes#jcite">885</a> &amp; n. 1 (1970). The reason for this rule
is that the physician "is in the best position to give a highly
individualized warning to a patient based on the physician's knowledge of
the patient and the inherent risks of the drug." <i>Koeiemba v. C.D. Searle &amp;</i>
<i>Co.</i>, <a href="/s/opinion/e1bfb618deb1fc6b1612e3c644864308/document/X2H3ET?jcsearch=680%20f%20supp%201293&amp;summary=yes#jcite">680 F.Supp. 1293</a>, <a href="/s/opinion/e1bfb618deb1fc6b1612e3c644864308/document/X2H3ET?jcsearch=680%20f%20supp%201293&amp;summary=yes#jcite">1305</a> (D.Minn.1988).
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<span class="fr"><a HREF="#fnref_fn600" name="fn600">[fn6]</a></span> The district court did not address these arguments under the standard
for JMOL because the district court "determined those arguments fail under
the less stringent standard of that for a new trial." We agree. <i>See</i>
<i>Clifford</i>, <a href="/s/opinion/e1bfb618deb1fc6b1612e3c644864308/document/XAU8L1?jcsearch=681%20north%20western%202d%20680&amp;summary=yes#jcite">681 N.W.2d at 687</a>.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<span class="fr"><a HREF="#fnref_fn700" name="fn700">[fn7]</a></span> Schedin was in Dr. Beecher's care, according to Dr. Beecher, for "15
minutes tops."
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<span class="fr"><a HREF="#fnref_fn800" name="fn800">[fn8]</a></span> We therefore do not reach OMJP's arguments for a new trial based on
errors relating to Schedin's punitive damages claim.
</p></div>
</div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  BYE, Circuit Judge, concurring in part and dissenting in part.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  I concur in affirming the district court's decision to deny OMJP's motions
for judgment as a matter of law and for a new trial with respect to the
jury's award of compensatory damages. I believe, however, there was
sufficient evidence from which a reasonable jury could conclude OMJP
deliberately disregarded the risk of tendon injuries in elderly patients who
were prescribed Levaquin in association with corticosteroids. I therefore
respectfully dissent from the decision to reverse the denial of OMJP's
motion for judgment <span CLASS="page_no" data-cite="2012 bl 313391 p 8" data-cite-type="Bloomberg" data-cite-pageno="8" data-primary-citation="">[**8]</span> as a matter of law on punitive damages.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  When reviewing the district court's denial of the motion for judgment as a
matter' of law on punitive damages, we "must draw all reasonable inferences
in favor of the nonmoving party, and . . . may not make credibility
determinations or weigh the evidence." <i>Reeves v. Sanderson Plumbing Prods.,</i>
<i>Inc.</i>, <a href="/s/opinion/e1bfb618deb1fc6b1612e3c644864308/document/X48SPU?jcsearch=530%20us%20133&amp;summary=yes#jcite">530 U.S. 133</a>, <a href="/s/opinion/e1bfb618deb1fc6b1612e3c644864308/document/X48SPU?jcsearch=530%20us%20133&amp;summary=yes#jcite">150</a>, <a href="/s/opinion/e1bfb618deb1fc6b1612e3c644864308/document/1?citation=120%20supreme%20court%202097&amp;summary=yes#jcite">120 S.Ct. 2097</a>, <a href="/s/opinion/e1bfb618deb1fc6b1612e3c644864308/document/X48SPU?jcsearch=147%20l%20ed%202d%20105&amp;summary=yes#jcite">147 L.Ed.2d 105</a> (2000). "Judgment
as a matter of law is appropriate only when all of the evidence points one
way and is susceptible of no reasonable inference sustaining the position of
the nonmoving party." <i>Howard v. Mo. Bone &amp; Joint Ctr., Inc.</i>, <a href="/s/opinion/e1bfb618deb1fc6b1612e3c644864308/document/X1E1O0E003?jcsearch=615%20f%203d%20991&amp;summary=yes#jcite">615 F.3d 991</a>,
<a href="/s/opinion/e1bfb618deb1fc6b1612e3c644864308/document/X1E1O0E003?jcsearch=615%20f%203d%20991&amp;summary=yes#jcite">995</a> (8th Cir.2010) (internal quotation marks and citation omitted).
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  In denying OMJP's motion for judgment as a matter of law, the district
court emphasized three points: (1) OMJP's knowledge of Levaquin's potential
for higher tendon toxicity; (2) OMJP's assistance in the design of the
Ingenix study with the motive to cloud the field of academic literature on
the topic of Levaquin's potential for higher tendon toxicity; and (3) OMJP's
failure to adequately warn prescribers of Levaquin's potential for higher
tendon toxicity. <i>See Schedin v. Ortho-McNeil-Janssen Pharm., Inc.</i>,
<a href="/s/opinion/e1bfb618deb1fc6b1612e3c644864308/document/X1G4SVM003?jcsearch=808%20f%20supp%202d%201125&amp;summary=yes#jcite">808 F.Supp.2d 1125</a>, <a href="/s/opinion/e1bfb618deb1fc6b1612e3c644864308/document/X1G4SVM003?jcsearch=808%20f%20supp%202d%201125&amp;summary=yes#jcite">1137</a> (D.Minn.2011). In reversing the district court, the
majority cryptically states "this motive allegation is mere speculation,"
<i>ante</i> at 1169, presumably disagreeing with the district court's second point.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The punitive damage award should not, however, rise or fall on whether the
jury reasonably found OMJP manipulated the Ingenix study. Even assuming the
jury rejected Schedin's allegations regarding the Ingenix study, the
evidence was more than sufficient to allow a reasonable jury to infer that
OMJP deliberately acted with indifference to a high degree of probability of
injury, <i>see</i> Minn.Stat. &sect; <a href="/s/opinion/e1bfb618deb1fc6b1612e3c644864308/document/XEUQMK003?jcsearch=Minn.%20Stat.%20%20549.20(1)&amp;summary=yes#jcite">549.20</a>(1), based on (1) OMJP's knowledge of the
serious risks associated with Levaquin's potential for higher tendon
toxicity when prescribed to elderly patients in conjunction with
corticosteroids, and (2) OMJP deliberately choosing a course of action
whereby physicians
<span CLASS="page_no" data-cite="700 f 3d 1171" data-cite-type="PrimaryFederalReporter" data-cite-pageno="1171" data-primary-citation="700 F.3d 1161">[*1171]</span> 
would not be adequately apprised of the increased risk.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Schedin presented evidence from which a jury could reasonably infer OMJP
was more concerned about its profits, and how those profits would be
affected by effective warnings, than it was about the possibility Levaquin
could injure elderly patients who were prescribed the drug in association
with corticosteroids. As early as 1999, OMJP was aware of an increased risk
of tendon disorders associated with the use of Levaquin in patients who had
been prescribed a steroid. Schedin presented evidence of OMJP's perception
of the regulatory action taken in Europe in response to numerous adverse
event reports associating Levaquin with tendon injuries, evidence which
showed OMJP connected an increase in regulation with a decrease in profits.
Included in this evidence was a memo in which OMJP linked the sending of a
Dear Doctor letter &mdash; something the jury's verdict on compensatory damages
clearly infers OMJP should have undertaken in order to satisfy its legal
duty to provide an adequate warning &mdash; directly to the company'<span CLASS="page_no" data-cite="2012 bl 313391 p 9" data-cite-type="Bloomberg" data-cite-pageno="9" data-primary-citation="">[**9]</span> s profits <i>vis</i>
<i>a vis</i> its marketing of Levaquin. "[I]f a Dear Dr letter has to go out and
consequently reporting goes up &mdash; as it will do, leading to an aggravation of
the situation and ultimate product withdrawal." Appellee's App. at 473.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The original label OMJP issued when it first began marketing Levaquin in
the United States contained no mention about the increased risks associated
with prescribing Levaquin to elderly patients. The evidence showed that it
is customary for physicians to rely upon Dear Doctor letters, and updates
from pharmaceutical representatives, whenever there is a significant change
in a product's labeling after its initial release into the marketplace. But
when OMJP revised Levaquin's labeling in 2002, it deliberately chose not to
issue Dear Doctor letters or even to instruct its pharmaceutical
representatives to advise physicians of the label change. Instead, OMJP
deliberately chose to bury the updated warning &mdash; a single twenty-word
sentence &mdash; inside thirty pages of fine print in the revised package insert,
and then took no further action to ensure physicians would be aware of the
label's revised warnings. The jury could reasonably infer OMJP chose this
course of action because issuing Dear Doctor letters, or instructing
pharmaceutical representatives to spread the word about the increased risk,
would have a direct and adverse affect on OMJP's profits.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Thus, contrary to the majority's conclusion that OMJP's conduct showed the
company "actively sought ways to prevent the dangers associated with its
product[,]" <i>ante</i> at 1169 (quoting <i>Beniek v. Textron, Inc.</i>, <a href="/s/opinion/e1bfb618deb1fc6b1612e3c644864308/document/X2TC89?jcsearch=479%20north%20western%202d%20719&amp;summary=yes#jcite">479 N.W.2d 719</a>,
<a href="/s/opinion/e1bfb618deb1fc6b1612e3c644864308/document/X2TC89?jcsearch=479%20north%20western%202d%20719&amp;summary=yes#jcite">723</a> (Minn.Ct.App.1992)), OMJP's deliberate choices virtually guaranteed that
physicians would remain unaware of the increased risk of prescribing
Levaquin to elderly patients in conjunction with corticosteroids. By
reversing the punitive damage award we encourage other pharmaceutical
companies to make the same devious choices OMJP made, instead of affirming
the jury's decision to deter such conduct.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  I concur in part, and respectfully dissent in part.
</p></div>
<!--BBLS DD 1750483009539-->

</div>
<div class='sideBar printHide clearfix '>
<!-- /Default state -->
<!-- /Display properties -->
<div class='tabsNotepad printHide'>
<div class='tabButtons clearfix'>
<div class='borderTab activeTab' id='buttonTab_general'>
<span>
General Info
</span>
</div>
<div class='borderTab inactiveTab' id='buttonTab_notePad'>
<span>Notepad</span>
</div>
</div>
</div>
<div class='sideBarInner clearfix'>
<div class='sideBarContent bootstrap sidebar ' id='tab_general'>
<div class='sidebarSection'>
<div class='sidebarTitle'>
<span class='left'>BCite Analysis</span>
</div>
<div class='sidebarSubsection sidebarSectionDivider bciteRenderer clearfix'>
<div class='sidebarSubhead bold'>
<a href="/bcite/X1IU8EM003/history">Direct History (363)</a>
</div>
<div class='sidebarItemLabel bold'>
No Negative Direct History
</div>
</div>
<div class='bciteRenderer clearfix sidebarSectionDivider sidebarSubsection'>
<div class='sidebarSubhead bold'>
<a href="/bcite/X1IU8EM003/analysis">Case Analysis (12)</a>
</div>
<div class='bciteResult'>
<img class='icon printOnly' src='/images/citation_icons/positive.png'>
<div class='citation icon positive printHide' title='Positive'></div>
<a class='citationAnalysisLabel' href='/bcite/X1IU8EM003/analysis?analysis=BCITE_POSITIVE_GROUP'>
Positive
</a>
<span class='citationNumberLabel'>
12
</span>
</div>
</div>
<div class='sidebarSubsection clearfix analysisLink'>
<div class='sidebarSubhead small'>
<a href="https://www.bloomberglaw.com/help/BCite_Indicators.htm" class="citatorRenderer">Description of BCite Indicators</a>
</div>
</div>

<div id='generalInfo'>
<div class='sidebarSection'>
<div class='sidebarTitle'>
<span>
General Information
</span>
</div>
<div class='sidebarSubsection sidebarSectionDivider'><div class='facetItemHeading'>Result(s)</div><div class='facetItemLabel'>Judgment Affirmed (In Part), Judgment Reversed (In Part)</div></div>
<div class='sidebarSubsection sidebarSectionDivider'><div class='facetItemHeading'>Industries</div><div class='facetItemLabel'>Pharmaceutical Manufacturing</div></div><div class='sidebarSubsection sidebarSectionDivider'><div class='facetItemHeading'>Related Docket(s)</div><div class='facetItemLabel'><a href="/s/opinion/e1bfb618deb1fc6b1612e3c644864308/document/X1Q6M1F3SPO2">11-03117 (8th Cir.)</a></div></div><div class='sidebarSubsection sidebarSectionDivider'><div class='facetItemHeading'>Topic(s)</div><div class='facetItemLabel'>Damages &amp; Remedies</div><div class='facetItemLabel'>Products Liability</div><div class='facetItemLabel'>Torts</div></div>
<div class='sidebarSubsection' id='judges_section'>
<div class='facetItemHeading'>Judge(s)</div>
<div id='judges_section_loader'></div>
</div>
</div>
</div>
</div>
</div>
<div class='sideBarContent clearfix notepad hidden' id='tab_notePad'>
<div id='notepad'>
<div class='notepadInstructions'>
Click anywhere in Notepad to add a note.
</div>
<div class='protoNote note'>
<a class='anchor'></a>
<div class='headerRow'>
<div class='ieFloat'>
<span class='title'></span>
<span class='date'></span>
</div>
<div class='ieFloat right'>
<a class='delete'>
Delete
</a>
<div class='toolDivider'>
|
</div>
<a class='edit'>
Edit
</a>
</div>
<div class='clearfix'></div>
</div>
<div class='body'></div>
<div class='footer'>
<div class='ieFloat'>
<a class='previous'>
Previous
</a>
</div>
<div class='ieFloat pageDisplay'>
<span class='numNoteDisplay'></span>
</div>
<div class='ieFloat right'>
<a class='next'>
Next
</a>
</div>
</div>
</div>
<div class='protoNoteEditor note'>
<div class='headerRow'>
<div class='ieFloat'>
<span class='title'></span>
<span class='date'></span>
</div>
</div>
<div class='body'>
<textarea class='contents'></textarea>
<div class='toolRow'>
<a class='save'>
Save
</a>
<div class='toolDivider'>
|
</div>
<a class='cancel'>
Cancel
</a>
<div class='clearfix'></div>
</div>
</div>
<div class='footer'>
<div class='ieFloat'>
<a class='previous disabled'>
Previous
</a>
</div>
<div class='ieFloat pageDisplay'>
<span class='numNoteDisplay disabled'></span>
</div>
<div class='ieFloat right'>
<a class='next disabled'>
Next
</a>
</div>
</div>
</div>
<div class='protoConfirmDelete'>
<div class='popupWindowOuter'>
<div class='popupWindowInner'>
<div class='clearfix popupTitle'>
<div class='close' onclick='closePopup()'></div>
<h2>
Delete Note
</h2>
</div>
<div class='popupContent'>
<div class='sectionLabel'>
Are you sure you want to delete this note?
<br>
<br>
<br>
<br>
</div>
</div>
<div class='popUpActions'>
<button class='bootstrap skinButton popup action right'>
<span>
Delete
</span>
</button>
<button class='bootstrap skinButton popup cancel right' onclick='closePopup()'>
<span>
Cancel
</span>
</button>
</div>
</div>
</div>
</div>
</div>

</div>
</div>

</div>
<div class='clearfix'></div>
</div>

<div class='keywordSearch' id='keyword_search'>
<a href="javascript:Blaw__findPrevKeyWord();redrawPrevNextButtons();" id="keyword_search_previous">Previous Keyword</a>
|
<a href="javascript:Blaw__findNextKeyWord();redrawPrevNextButtons();" id="keyword_search_next">Next Keyword</a>
</div>
<div class='pageLoader'></div>
<div class='browserPopupContainer' id='browserPopup'>
<div class='browserTitle'>
<div class='close' onclick='$("#browserPopup").bbTocBrowser(false);'></div>
<h2 class='popup_title'></h2>
</div>
<div class='browserPopupContent popup_content' id='browserPopupContent'></div>
</div>
<div class='maskOverlay' id='ajax_browser_mask'></div>


<div class='clearfix'></div>
</div>
</div>
<!-- _enter_client_matter.haml begin -->
<div class='clientMatterContainer hidden' id='clientMatterContainer'>
<form accept-charset="UTF-8" action="/client_matter/session/create" id="startClientMatterSessionForm" method="post"><div style="margin:0;padding:0;display:inline"><input name="utf8" type="hidden" value="&#x2713;" /><input name="authenticity_token" type="hidden" value="NiJ+70/qv61N1TFnbttr4ZzRa7IGhB5DMvou0CKGUXA=" /></div>
<input id="create_client_matter" name="create_client_matter" type="hidden" value="false" />
<div class='clearfix popupTitle'>
<div class='close' onclick='cancelClientMatterPopup()'></div>
<h2>
Enter a Client Matter
</h2>
</div>
<div class='popUpContent'>
<div class='clientMatterPopupHeader'>
Your firm optionally allows a client matter to be selected while you are using Bloomberg Law.
Please select from a recently used Client Matter or enter a Client Matter manually.
</div>
<div class='error' id='clientMatterLabelErrors' style='display:none'></div>
<div class='error' id='attorneyNumberLabelErrors' style='display:none'></div>
<div class='row sources clearfix'>
<div class='labelHolder'>
<span class='label'>Client Matter</span>
</div>
<div class='inputContainer'>
<input autocomplete="off" class="autocompleteTextField input_auto autocompleteForm" data-context="CLIENT_MATTERS" data-highlight-term="true" data-select-callback="applyClientMatterFromAutocompleteSelection" data-show-no-matches="false" data-url="/autocomplete/lookup" id="client_matter_label" name="client_matter_label" type="text" value="" />
<script type="text/javascript">
//<![CDATA[
jQuery().ready(function ($) { $('#client_matter_label').bbAutocomplete(); });
//]]>
</script>
</div>
</div>
<div class='row clientMatterSuppressionCheckholder' id='clientMatterSuppressionCheckholder'>
<label>
<input id="suppress_client_matter_prompt_enabled" name="suppress_client_matter_prompt_enabled" type="hidden" value="1" />
<input checked="checked" id="suppress_client_matter_prompt" name="suppress_client_matter_prompt" type="checkbox" value="1" />
<label for="suppress_client_matter_prompt">Do not remind me again this session</label>
</label>
</div>
<div class='clientMatterText'>
Please contact your administrator if you have questions about client matter.
</div>
</div>
<div class='popUpActions'>
<button class='bootstrap skinButton popup right' type='submit'>
<span>
Submit
</span>
</button>
<button class='bootstrap skinButton popup cancel right' onclick='cancelClientMatterPopup();' type='button'>
<span>
Cancel
</span>
</button>
</div>
</form>

<div id='createClientMatterForm' style='display:none'>
<div class='clearfix popupTitle'>
<h2>
Unrecognized Client Matter
</h2>
</div>
<div class='div'>
Client Matter
<span id='new_client_matter_label'>&nbsp;</span>
does not currently exist in Bloomberg Law. Would you like to add this client matter to the system?
</div>
<div class='popUpActions'>
<button class='bootstrap skinButton popup action right' type='button'>
<span>
Yes
</span>
</button>
<button class='bootstrap skinButton popup cancel right' type='button'>
<span>
No
</span>
</button>
</div>
</div>
</div>
<!-- _enter_client_matter.haml begin -->

<div id='loading_container'></div>
<div class='fixedControls menuHolder printHide' id='bottom_menu_row'>
<div class='menuButton' id='pde_tray_menu'>
<div class='queueImageHolder'></div>
<div class='indicator num_of_pde_tray_items'></div>
</div>
<div class='clearfix'></div>
</div>
<div class='menuItem bottomMenu' id='pde_tray'>
<div class='inner'>
<div class='heading'>
<div class='title'>
Queue
<span class='indicator num_of_pde_tray_items'></span>
<!-- =pde_tray_count_from_session -->
</div>
<div class='bootstrap closeIcon right' id='pde_tray_close_button'></div>
<div class='clearfix'></div>
</div>
<div class='actions hasItems' id='pde_tray_has_items'>
<div class='selection'>
<div class='trayCheckHolder'>
<input id='pde_tray_select_all' type='checkbox'>
</div>
Select All
</div>
<div class='tools'>
<a onclick='javascript:PDETray_default.downloadSelection();'>
Print/Download
</a>
|
<a onclick='javascript:PDETray_default.emailSelection();'>
Email
</a>
|
<a onclick='javascript:PDETray_default.workspaceSelection();'>
+ Workspace
</a>
|
<a onclick='javascript:PDETray_default.deleteSelection();'>
Delete
</a>
</div>
<div class='clearfix'></div>
</div>
<div class='actions noItems' id='pde_tray_no_items'>
<div class='title'>
You have no items in your Queue
</div>
<div class='clearfix'></div>
</div>
<div class='itemsHolder' id='pde_tray_items'></div>
</div>
</div>

<div class='maskOverlay' id='pde_tray_mask'></div>

<script language='javascript'>
var SHOW_AUDIT = false;
var ROOT_PATH = "/";
var RAILS_ROOT = "/";
var CONTEXT_PATH = "/";
var DOC_ROOT_PATH = "/s/opinion/e1bfb618deb1fc6b1612e3c644864308/";
var RESULTS_ROOT_PATH = "/search/results/";
var SELECTED_CONTEXT = "";
var MODULE_PATH;
MODULE_PATH = "/document";
var CRUMB_ID = "e1bfb618deb1fc6b1612e3c644864308";
var BILLING_CONFIGURATION = {"DOCKET":true,"NEWS":false,"LAW":true,"ADVANCED_LEGAL":true,"PATENT":true,"PATENT_ASSIGNMENT":true,"PEOPLE":false,"OPINION":true,"CITATION":false,"BREAKING":true,"DOCKET_REQUESTS":true,"COMPANY_FILINGS_EDGAR":false,"COMPANY_FILINGS_DOCKETS":false,"COMPANY_FILINGS_OTHER":false,"CORP_ACTIONS":true,"ECO_SEARCH":true,"EDGAR_SEARCH":true,"EXAMPLE_DOCUMENTS":true,"CLAUSE_SEARCH":true,"LEG":true,"REG":true,"BOOLEAN":false,"SIMPLE":false,"COMPANY_DOCKETS":true,"TOC_SEARCH":true,"IMMUTABLE_LAW_SEARCH":true};
var CONTEXT_BILLING_POLICY_KEY = "";
var ELITE_ENABLED = false;
var CLIENT_MATTER_PROMPT_ENABLED = false;
var CLIENT_MATTER_ON_LOGIN_ENABLED = false;
var SUPPRESS_CLIENT_MATTER_PROMPT = false;
var clientMatterActive = false;
var currentClientMatter = '';
var currentAttorneyNumber = '';
var clientMatterHaltedForm = null;
var USER_ID = 'un=373038066';
var SESSION_ID = '63166_a5929cc15e1bfd637ed52768bec5d196';
var NTPT_REDIRECTED_EVENT = '';
var NTPT_PGEXTRA = '&activityType=ENTITY&subActivityType=DOCUMENT_VIEWED&pageId=&activityInstanceId=ENTITYb3560e&previousPageId=&previousActivityInstanceId=ENTITY5760d5&previousActivityType=ENTITY&previousSubActivityType=DOCUMENT_VIEWED&previousActivityTime=2014-02-02T07:31:47-05:00';
var NTPT_GLBLEXTRA = 'un=373038066&sessionId=63166_a5929cc15e1bfd637ed52768bec5d196&auth=true';
var BROWSER_COMPATIBILITY_WARNING = 'false';
var SHOW_MODAL = false;
var JUG;
$(document).ready(function(){
setTimeout(framework_getPageState,500);
framework_bindGlobalResizeElements();
notepad_onDocumentLoaded();
<!-- /DRQS 24932463 -->
$("#downloadPopupLinkForm a").removeAttr("href");
$('#startClientMatterSessionForm').submit(function() {
  createClientMatterSessionFromForm(this);
  return false;
});

var t = $('.clientMattersTableEl');

jQuery.each(t, function(name, value) {
  try {
    var this_value =  $.trim(String(value.innerHTML));
    var this_final_value = this_value.length > 22 ? this_value.substring(0,9)+"..." : this_value;
    value.innerHTML = this_final_value;
  } catch (e) {}
});

$('#startClientMatterSessionForm .recentlyUsed td').click(function() {
  $('#client_matter_label').val($.trim($(this).attr("title")));
});

});
</script>
<script type='text/javascript'>
DOCUMENT_SHOW_SIDEBAR="true";
DOCUMENT_HAS_SIDEBAR_INFO="true";
DOCUMENT_IS_IFRAME="";
NTPT_PGEXTRA = 'documentSearchType=OPINION&docId=X1IU8EM003&docType=OPINIONS&contentClass=LEGAL&activityType=ENTITY&subActivityType=DOCUMENT_VIEWED&pageId=&activityInstanceId=ENTITY5760d5&previousPageId=&previousActivityInstanceId=ENTITY9e067e&previousActivityType=ENTITY&previousSubActivityType=DOCUMENT_VIEWED&previousActivityTime=2014-02-02T07:31:44-05:00';
FLUID_LAYOUT="false";
FULL_DOC_ID = 'X1IU8EM003';
NOTEPAD_UUID="11082191";
NOTEPAD_DOC_ID="X1IU8EM003";
$('#page_loader').show().spin();
JUDGE_IDS=["3046086","3593626","4247982"];
JUDGE_NAMES=null;
</script>

<script src="/javascripts/activity_tracking/ni.js?1376494218" type="text/javascript"></script>
<script src="/javascripts/activity_tracking/tracking.js?1384975732" type="text/javascript"></script>
<div class='footer'>
<div class='footerContent printHide'>
<div class='logoContainer grid eight'>
<div class='copyright'>
&copy; 2014 The Bureau of National Affairs, Inc. All Rights Reserved.
 | 
<a href="#" class="menuLink" onclick="open_tos_or_privacy('X3BPR08'); return false;">Terms of Service</a>
 | 
<a href="#" class="menuLink" onclick="open_tos_or_privacy('X3BPH08'); return false;">Privacy Policy</a>
</div>
<a class='logo' href='/home'></a>
<div class='version'>
2.
231154
Gem
0.176.7
231497
 - 3.0.20
</div>
<div class='helpContainer'>
<div class='helpDesk'></div>
<a href="/help/BLAWHelpSystem.htm#Contact_Us.htm" class="menuLink">Submit Feedback</a>
 | 
<a href="mailto:blawhelp@bna.com" class="menuLink">blawhelp@bna.com</a>
</div>
</div>
</div>

</div>
</div>
</body>
</html>
